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Chapter 1 
 
 
1.6 Secondary metabolites and their role in nature 
 
When the first so-called secondary metabolites were found, up to the 60’s, they were 
considered as “waste products” of primary metabolism, and the accumulation of those 
substances in cells was attributed to the absence of an efficient excretory system in plants. 
However not everybody was convinced with this idea, and after some studies performed, 
they were describe as “trigger” substances that induce or prevent the uptake of nutrients by 
herbivore, as described by Ehrlich and Raven in 1964, which were the first to propose an 
ecological role for those substances as defense agents against insect herbivore. Research 
was therefore initiated in many laboratories to attempt to establish the defensive role of 
secondary metabolites (Harborne, 2001). 
Different factors must being considered when we refer to secondary compounds, their role 
in plants and in nature. First of all is important to know which of those constituents is 
active, and how their concentration fluctuated during the life of the plant. Their localization 
is an important aspect. 
Environmental parameters can dramatically influence the production and concentration of 
secondary metabolites, especially in leaf tissue; indeed we can found variations in 
chemistry between plants in the same population, furthermore between leaves on the same 
branch. The dietary impact of those compounds on the herbivore is associated to their 
relative solubility, so do as their relative stability within the plant and the rate of turnover.     
Plant toxins are also effective against animals; an evidence is the fact that insects that feed 
on some species are able to assimilate certain toxins and use it to protected themselves from 
birds or other predators. 
Moreover some of these compounds synthesized by plants are also useful to attract some 
kind of animals that carry out pollination and distribute the seed. 
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Secondary compounds also demonstrated to have a role in the interactions between plants 
and microorganism since both of them produce such constituents, in one case to damage the 
higher plant hosts, while higher plants use these substances to defend themselves from 
microbial infection.     
Besides secondary metabolites can mediate hostile or beneficial interactions between plants 
growing in a given natural ecosystems. This kind of interaction is called “allelopathy”. 
Secondary plant constituents can be exported from the plant into the soil via the root. The 
concentrations thus exuded could be quite low; nevertheless they may have significant 
effects on bacteria and fungi that inhabit the soil around the plant roots. 
One way in which a higher plant might reduce the “metabolic costs” of synthesizing and 
storing toxins is to produce the defense agent only when it is actually needed.  
Toxins needed for protection are storage, in vacuoles in most of the cases, in a safe inactive 
bound form in plants, for example attached to a sugar.   
 
1.7 Use of medicinal plants in Ecuador  
 
About 80 % of the population of Ecuador depends on the traditional medicine for its health, 
thus on plants or natural products (Buitrón, 1999). This tendency is growing due to 
different reasons as for example the difficulties that population has to access to medical 
attention based on commercial drugs and to medical social security. The use of traditional 
medicine becomes everyday more common not just in rural areas, by indigenous people, or 
in poor urban neighborhoods, but in general as a result of the search for effectiveness, 
reduction of  harmful practices in the treatment of illnesses, low costs and to avoid 
collateral effects caused sometimes by some chemicals products. 
 Nevertheless most part of the species from Ecuador have not been identified, selected or 
test in an efficiently way, in order to be include in the national list of drugs, leading to a 
lack of stimulus for their production and appropriate use. It must be more interest to 
encourage research, to develop management and conservations programs that promote their 
agronomic production, chemical study and industrialization.  
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In addition, as it happens with commercial drugs, the indiscriminate use and the self-
medication with natural products cause problems, since in Ecuador is very easy to find and 
buy medicinal plants or natural products derived from them, never tested before in a 
scientific way and without any quality control, in urban or rural markets, handicraft, and 
pharmacy stores. The fact that appropriated standardization process and good practice of 
production are not applied increase the risk of the use of natural products. These kinds of 
difficulties bring to the lost of the knowledge and the resources. 
Ecuador has a very rich biodiversity, but from all the vast number of species corresponding 
to medicinal plants only 500 are known. For the most part of these species there is not 
enough scientific information or an ecological profile that could help to find the best 
conditions to obtain and produce sufficient raw material to satisfy the existing demand. 
Plants growing in the zone of the Cordillera de los Andes, where the species concerning 
this work has been collected, are the better known and the most demanded (Buitrón, 1999). 
Most of the time the collection of the species is carried out directly by consumers, as in the 
case of indigenous people for daily consumption. The whole plant could be used or 
commercialize as raw material, or in parts, pulverized, as extracts or as semi-synthetic 
substances. People use medicinal plants for infusions, to treat different sickness as 
headache, back pain, skin illness, or as antibiotics, antifungal, among others.    
This is why it becomes indispensable to improve the research in this field in Ecuador, to 
conserve the species and their habitats, improving the use and trade of medicinal plants and 
derivative products, in order to benefit the population’s health. Is important to enrich the 
knowledge about the chemical content of these species, to reach a better understanding 
about their properties and encourage an appropriate consumption and use of natural 
products.  
  
1.8 Bioactive compounds from natural sources and drug discovery  
 
The evolution of secondary metabolites has resulted in diverse, more or less complex 
natural chemicals able to interact with a variety of targets from other organisms and 
environment. The biosynthesis and selection of these chemical entities enhance organisms 
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survival and competitiveness. Their bioactive nature and diversity render these chemical 
compounds the most profitable and efficient source of new drug leads. 
Natural product preparations, mainly herbal remedies, have historically been the major 
source of pharmaceutical agents. Even today about 70 % of the world´s population relies 
upon medicinal plants for its primary pharmaceutical care (Rosen et al., 2009). 
Natural product research is a demanding task in the sense of supply of natural material, 
analytics, reproducibility, isolation procedure, structure elucidation and chemical 
complexity. 
Clues for an idea about the bioactivity of a novel natural compound may be provided from 
the interacting ecosphere itself, for example, microorganism or herbivores that can be 
repelled successfully, or animals are observed to their exposure to natural materials and 
their subconscious, instinctive or conscious application to treat and cure impairments. 
The advancement in bioassay technology and high throughput screening has perhaps been 
one of the strongest factors for the reemerging role of natural products in drug discovery 
and development over the last decades (Rosen et al., 2009). Nevertheless, nowadays it 
remains a challenge, in the analysis and evaluation of the obtained results, to understand 
more about their activity, depending on lot of parameters as concentration, additive and 
synergistic effects, as well as assay or agents that could disturb metabolites activity.    
Nowadays natural product compounds become the source of numerous therapeutic agents. 
Compounds with an important activity to treat cancer, resistant bacteria and virus, so as 
immunosuppressive disorders have been developed thanks to recent progress in techniques 
directed to discover drugs from natural product sources (Gullo et al., 2006). 
In the areas of cancer and infectious disease, 60 and 75% respectively, of new drugs, 
originate from natural sources. Whereas compounds derived from natural products 
represent 78% of commercial antibacterials (Gullo et al., 2006). Nevertheless there is a 
continuing need to discover novel active substances since antibiotic resistance by pathogens 
limit the efficiency of marketed products.    
One of the main challenges in this field is how to determine desirable biological activity. In 
the beginning empirical observations by native people allowed to have an idea about which 
plant and animal products were effective for a variety of diseases. Through the years a new 
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process with more scientific basis, known as screening, took place. It consists on search 
compounds with a predefined set of biological activities by surveying as much diversity as 
it is possible. Nevertheless considering the vast number of species of plants in nature, 
besides the fact that just a very small part of those have been evaluated for their biological 
activity, it would take too much time to reach the goal. Thus a second approach very useful 
is the one we mentioned before, that is to control the information provided by indigenous 
cultures about the uses they give to natural products to prevent or treat diseases. This 
discipline known as ethnopharmacology, is a mix of sociology, medicine, anthropology and 
botany (Clark, 1996).   
These cultures have continued to use vegetal material for very long time because of its 
effectiveness. Hence the need to record and validate this knowledge, as it is passed from 
generation to generation orally and there is a risk to lose it. However some cultures 
registered in written from the information. It is the case of the Chinese “Materia Medica”, 
where are reported details of the classification, description, preparation and uses of 
medicinal plants. 
In order to find potential lead compounds by a phytochemical study, the first step is the 
choice of the plant material on the basis of chemotaxonomic and phylogenetics features, 
ethnobotanic and/or other literature information.  
Generally, since the starting point is a heterogeneous extract, it is necessary the 
fractionation and identification of the bioactive components carried out often with the help 
of biological assays. Then the pure compounds have to be characterized. The process to 
obtain pure molecules from the natural source is complex and usually yields small amounts 
of the product. Many extraction and chromatographic techniques are required, and the 
characterization is obtained thanks to nuclear magnetic resonance (NMR) and mass 
spectrometry (MS) analysis. The method is described in Figure 1.1.  
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Figure 1.1: Compounds 
isolation and structural 
characterization scheme 
 
Introduction Chapter 1 
 
- 7 - 
 
1.9 The aim of the thesis project 
 
The title of my PhD thesis is “Chemical study of plants belonging to Ecuadorian flora”. 
I performed my research at the Dipartimento di Farmacia of the University of Pisa, working 
with the phytochemical group under the supervision of Prof. Alessandra Braca. Among all 
the projects in this research laboratory, there is the investigation of plants growing in the 
developing countries of South America, Africa, Middle East and Asia. 
 
The aims of my research were:  
To isolate and characterize bioactive compounds from medicinal plants collected in 
Ecuador following this experimental protocol:  
-Selection of the plant 
-Extraction from the natural source 
- Isolation of pure compounds 
-Structural characterization 
-Elucidation of biological activity 
To discover biologically active plants from Ecuador that could be useful in the medical 
field, starting from the knowledge about their use as natural remedies in the traditional 
medicine, in order to find scientific arguments that support these uses. 
To show the importance of this kind of research, mainly in countries as Ecuador with such 
rich biodiversity, not just to contribute with the scientific community but giving resources 
that could  provide scientific material to encourage the research and the development in the 
country and improve quality of life and health. 
 
In this framework I studied five species that have not been studied before for their chemical 
content despite their use in traditional medicine, and that belong to interesting plant 
families:  
Siparuna thecaphora (Poepp. Et Endl) A.DC. (Monimiaceae), Bidens humilis (Kunth) 
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(Asteraceae), Andromachia igniaria (Humb.& Bonpl.) (Asteraceae), Euphorbia laurifolia 
(Juss. Ex Lam.) (Euphorbiaceae), and Clinopodium tomentosum (Kunth) Harley 
(Lamiaceae).  
The work on all plants deals principally with the isolation and structural characterization of 
secondary metabolites by using different chromatographic separation technique, NMR 
spectroscopy, and mass spectrometry. For two species different test were carried out to 
analyses the specific biological activity of the samples.   
 
1.10 Content of the thesis 
 
The results of the research on Siparuna thecaphora, Clinopodium tomentosum, Euphorbia 
laurifolia, Bidens humilis and Andromachia igniaria are reported in the Chapters 3 to 7, 
with all the new and known compounds isolated and characterized through 
chromatographic, spectrometric and spectroscopic techniques. In the case of E. laurifolia 
and B. humilis different biological test were applied to a pure new compound in the first 
case, and to the extracts and to the new and known isolated compounds obtained in the case 
of the second species. The results and details are reported in their respective chapters.   
Conclusions of the thesis are finally reported in a unique session. 
 
 
 
  
 
 
 
 
 
 
 
 
CHAPTER 2 
                Materials and methods  
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Chapter 2 
 
 
2.1 Chromatographic techniques 
 
2.1.1 Thin Layer Chromatography (TLC) 
 
TLC (Figure 2.1) was performed on precoated kieselgel 60 F254 plates (Merck), 0.25 mm 
thick, with glass or aluminium as support. The spots were revealed using UV detection with 
lamp at 254 or 366 nm and successively using a specific spray reagent, allowing to the 
development of typical colouring that can give information about the nature of examined 
compounds. As eluting solvents in the TLC analyses, some mixtures of solvents were 
mainly used: CHCl3:MeOH (99:1), CHCl3:MeOH (98:2), CHCl3:MeOH (97:3), 
CHCl3:MeOH (95:5), CHCl3:MeOH  (9:1), CHCl3:MeOH:H2O (40:9:1), 
CHCl3:MeOH:H2O (70:30:3), n-BuOH:AcOH:H2O  (60:15:25). 
CeSO4/H2SO4, a general reactive, was used to reveal all compounds contained in mixtures. 
It is a saturated solution of cerium sulphate in 65% sulphuric acid. Heating at 120°C for 15 
min is needed to reveal the spots.  
Other reactives were also used in this work: 
NTS/PEG:  adopted commonly for polyphenolic compounds such as flavonoids or 
coumarins. It corresponds to a mixture of the following solutions:   
Naturstoff reactive (NTS) = β-ethylaminic diphenylboric ester in methanol solution 1% and 
Polyethylene glycol 4000 (PEG) in ethanol solution 5%.  
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Figure 2.1: TLC 
 
2.1.2 Column Chromatography  
 
2.1.2.1 Gel Filtration Chromatography 
 
Gel filtration chromatography was performed over Sephadex LH-20 (25-100 µm, 
Pharmacia Fine Chemicals) using columns 3 x 100 cm, for 2-4 g of extract, and 5 x 100 cm 
for 5-10 g of material, and a peristaltic pump Pharmacia Fine Chemicals P1. The eluent was 
always methanol, at constant flow rate (0.8 mL/min).  
 
2.1.2.2 Flash Chromatography 
 
Some separation were carried out with Biotage
®
 Isolera
®
 Spektra (Figure 2.2) for flash  
purification system to improve fractions and compound purity with λ detection and PDA 
spectral analysis at 254 and 320 nm. Cartridge size, related to the quantity of the mixture 
charged, is reported in Table 2.1.  
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Figure 2.2: Biotage
®
 Isolera
®
 Spektra 
 
Table 2.1. Biotage
®
 Isolera
®
 parameters 
Cartridge 
(g) 
Load capacity 
(mg) 
Flow rate 
(ml/min) 
10 100-500 10-20 
25 250-1250 15-40 
50 500-2500 30-50 
100 1000-5000 30-50 
340 3400-17000 65-120 
 
2.1.2.3 High Performance Liquid Chromatography (HPLC) 
 
Reverse-phase HPLC separations (Figure 2.3) were conducted on a Shimadzu LC-8A 
series pumping system equipped with a Shimadzu RID-10A refractive index detector and 
Shimadzu injector on a C18 µ-Bondapak column (30 cm x 7.8 mm, 10 µm Waters, flow rate 
2.0 ml/min). MeOH:H2O mixtures were used as mobile phases.  
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 Figure 2.3: HPLC system  
 
2.1.2.4 High Performance Centrifugal Chromatography (HPCPC) 
 
HPCPC was carried out on a EverSeiko CPC240 apparatus (Figure 2.4) equipped with 
3136 cells (ᶲ 15 mm and 240ml), Eluting with mixtures of solvents accurately selected on 
the basis of chemical composition of sample. 
 
 
 Figure 2.4: HPCPC system  
 
2.2 Nuclear Magnetic Resonance analyses (NMR) 
 
NMR experiments were performed on Advance Bruker 250 spectrometer (Figure 2.5) and 
Bruker DRX-600 spectrometer at 300 K. All the 2D NMR spectra were acquired in CD3OD 
in the phase-sensitive mode with the transmitter set at the solvent resonance and TPPI 
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(Time Proportional Phase Increment) used to achieve frequency discrimination in the ω1 
dimension. 
Standard pulse sequences and phase cycling were used for DQF-COSY, TOCSY, HSQC, 
HMBC, and ROESY experiments. NMR data were processed on using xwin-NMR 
software. 
Chemical shifts were expressed in δ (parts per million) referred to the solvent peaks δH 3.34 
and δC 49.0 for CD3OD. 
 
 
Figure 2.5: Advance Bruker 250 NMR spectrometer 
 
2.3 Mass Spectrometry analyses (MS) 
 
MS and MS
n
 analyses (positive and negative mode) were obtained using a LCQ Advantage 
spectrometer (Thermo Finnigan, San Jose, CA, USA) equipped with an ion trap analyzer 
and Xcalibur 3.1 software (Figure 2.6). All the analyzed molecules were dissolved in 
MeOH and then diluted to 10-20 µm/mL. Samples were injected into the spectrometer at a 
flow rate of 5 µL/min using an external syringe pump.  
HRESIMS were achieved using a nano LC-MS/MS system, with a nanoAcquity UPLC 
module and a Q-TOF premiere spectrometer equipped with a nanoelectrospray ion source 
(Waters-Milford, MA, USA), and provided with a lock-mass apparatus to perform a real-
time calibration correction. 
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Liquid chromatography separation of Bidens humilis extracts were achieved using a Luna 
C18 (150 x 2.1 mm, 2.5 µm Phenomenex, Palo Alto, USA) and 0.1% formic acid in water 
(A) and acetonitrile (B). Compounds elution was performed using a linear gradient from 1 
% to 50 % of B in 45 minutes. Mass spectra were acquired both in positive and in negative 
ion mode, over the 200-800 m/z range. Source temperature was set at 120 °C, capillary 
voltage 3300 eV, and cone voltage 50 eV. HRESIMS/MS spectra were acquired for the 
three most abundant ion observed in each MS spectrum (dependent scan mode). When 
required, HRESIMS/MS spectra were acquired, setting specific parent ion in the mass 
spectrometry method. 
 
 
Figure 2.6: Mass spectrometer 
 
2.4 Optical Rotation analyses 
 
Optical rotations analyses were measured on a Perkin–Elmer 241 polarimeter (Figure 2.7) 
equipped with a sodium lamp (589 nm) and a 1 dm microcell.   
  
 
Figure 2.7: Polarimeter 
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2.5 Ultraviolet-Visible (UV) Spectroscopy 
UV spectra were recorded on a Perkin–Elmer–Lambda Spectrophotometer (Figure 2.8). 
Samples were disolved in MeOH. 
 
 
 Figure 2.8: Spectrophotometer  
 
2.6 Acid Hydrolysis  
 
A solution of each compound (2.0 mg) in 1 N HCl (1 ml) was stirred at 80 ºC in a 
stoppered reaction vial for 4 h. After cooling, the solution was evaporated under a stream of 
N2. The residue was dissolved in 1-(trimethylsilyl) imidazole and pyridine (0.2 ml), and the 
solution was stirred at 60 ºC for 5 min. After drying the solution, the residue was 
partitioned between H2O and CHCl3. The CHCl3 layer was analyzed by GC using a L-CP-
Chirasil-Val column (0.32 mm x 25 m). Temperatures of both the injector and detector 
were 200 ºC. A temperature gradient system was used for the oven, starting at 100 ºC for 1 
min and increasing up to 180 ºC at a rate of 5 ºC/min. Peaks of the hydrolysate were 
detected by comparison with retention times of authentic samples of D-xylose, L-arabinose, 
L-rhamnose, and D-glucose (Sigma–Aldrich) after treatment with 1-
(trimethylsilyl)imidazole in pyridine. 
 
2.7 Biological activity 
 
2.7.1 Drug Affinity Responsive Target Stability (DARTS) 
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Drug Affinity Responsive Target Stability (DARTS) is a general methodology for 
identifying and studying protein-ligand interactions. The technique is based on the principle 
that when a small molecule compound binds to a protein, the interaction stabilizes the 
target protein’s structure such that it becomes protease resistant. DARTS is particularly 
useful for the initial identification of the protein targets of small molecules, but can also be 
used to validate potential protein-ligand interactions predicted or identified by other means 
and to estimate the affinity of interactions. The approach is simple and advantageous 
because it can be performed using crude cell lysates or other complex protein mixture 
(without requiring purified proteins), and uses native, unmodified small molecules 
(Lomenick et al., 2011). 
 
2.7.1.1 Cell lysates 
 
Human prostate cancer (PC3) and human breast adenocarcinoma (MCF7) cell lines were 
lysed in PBS containing 0.1% Igepal (lysis buffer) and a protease and phosphatase inhibitor 
cocktail (P8340, Sigma-Aldrich, St. Louis, MO, USA). Protein concentration was 
determined by Bio-Rad DC Protein Assay (Bio-Rad, Hercules, CA, USA) using bovine 
albumin as standard. Lysates (50 μg) were incubated with 5 μl of PBS 8.5% DMSO or 5 μl 
of compound 4 of Euphorbia laurifolia 200 μM 8.5% DMSO in PBS, to obtain the final 
concentration of 20 μM 1% DMSO for each small molecule studied. The samples were 
incubated for 1 hour at 4 °C under stirring. Samples were then underwent proteolysis with 
subtilisin (enzyme: lysate 1:750 w/w for 60 min at 30 °C) followed by 10% SDS-PAGE 
analysis. In fact, to stop proteolysis, 5 μl of Laemmly Buffer 4X was added to each sample 
and incubated at 100 °C for 2 min. 
 
2.7.1.2 Gel digestion 
 
In gel digestion by trypsin was performed as described in Dal Piaz et al., 2013. Briefly, the 
lane of interest were excised manually and analyzed as follow: gel pieces were discolored 
and de-hydratated in CH3CN. Subsequenty, samples were subjected to reduction in 10 mM 
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dithiothreitol (DTT) for 1 hour at 56 °C and alkylated in 55 mM iodoacetamide (IAA) for 
30 min at r.t. in the dark. Samples were washed again, with CH3CN and ammonium 
bicarbonate 100 mM and finally digested with 30 µl of trypsin, from porcine pancreas 
(SIGMA) at a final concentration of 0.013 ng/µl. Supernatans were collected, vacuum 
dried, dissolved in 15 µl 5% formic acid for MS analysis (Dal Piaz et al., 2013). 
 
2.7.2 Chemicals  
 
Sodium acetate trihydrate, DPPH, 2,4,6-tripyridyl-s-triazine (TPTZ), Iron (III) chloride 
(FeCl3*6H2O), β-carotene, linoleic acid, Tween 20, butylhydroxytoluen (BHT), Folin-
Ciocalteu reagent, sodium carbonate, 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic 
acid (Trolox) and gallic acid were purchased from Sigma-Aldrich (Milano-Italy). n-
Hexane, chloroform, methanol, hydrochloric acid and glacial acetic acid were purchased 
from VWR (Milano-Italy).  
 
2.7.3 DPPH radical-scavenging activity 
 
The ability to scavenge the DPPH free radical was monitored according to the method 
reported by Milella et al. (2014) with slight modifications. All samples were tested 
individually at different concentrations by addition to a methanol solution of DPPH radical 
(100 µM). For each measure 50 µL appropriately diluted sample was added to 200 µL of 
DPPH reagent, the mixtures were stirred and allowed to stand in the dark at room 
temperature. In the control 50 µL of methanol, instead diluted sample was added to 200 µL 
of DPPH solution. The absorbance of the resulting solutions was measured at 515 nm after 
30 min. In all experiments Trolox radical scavenging activity was also determined and used 
as a reference. Sample activity was expressed as mg of Trolox equivalents per gram of 
sample (mg TE/g). Each reaction was performed in triplicate and results expressed as mean 
± standard deviation (Padula et al., 2013). 
 
2.7.4 Ferric reducing antioxidant power (FRAP) assay 
Experimental section Chapter 2 
 
- 18 - 
 
The FRAP assay was carried out as described by Russo et al. (2012) with slight 
modifications. The FRAP reagent was made fresh before each experiment and it was 
prepared by mixing 300 mM acetate buffer in distilled water pH 3.6, 20 mM FeCl3*6H2O 
in distilled water and 10 mM TPTZ in 40 mM HCl in a proportion of 10:1:1. For each 
sample 25 µL of appropriately diluted sample (25 µL of methanol for the blank) and 225 
µL of FRAP reagent was added and incubated at 37°C for 40 min in the dark. Absorbance 
of resulting solution was measured at 593 nm. Trolox was used as a reference antioxidant 
standard and FRAP values were expressed as mg Trolox equivalents per gram of sample 
(mg TE/g). Each reaction was performed in triplicate and results expressed as mean ± 
standard deviation (Russo et al., 2012). 
 
2.7.5 β-Carotene bleaching (BCB) assay 
 
For this assay the following reagents were mixed: β-Carotene solution (0.2 mg of β-
carotene dissolved in 0.2 mL of chloroform), linoleic acid (20 mg) and Tween 20 (200 mg). 
Chloroform was removed by using rotary evaporator at room temperature (Russo et al., 
2012). Distilled water (50 mL) was added with oxygen, then 950 µL of the emulsion were 
transferred into several tubes containing 50 µL of sample (the final concentration for all 
tested samples was 0.05 mg/mL) or methanol as blank. BHT was used as positive control. 
Next, 250 μL of emulsion-sample solution was transferred (250 μL/well) to the reaction 
plate. Since the reaction was temperature-sensitive, close temperature control throughout 
the plate was essential in this assay; therefore outer wells were filled with 250 μL of water 
to provide a large thermal mass (Mikami et al., 2009). The microplate was immediately 
placed at 50°C for 3 h and the absorbance was measured at 470 nm at 0’, 30’, 60’, 90’, 
120’, 150’, and 180’. Each sample was carried out in triplicate and results expressed as 
mean ± standard deviation. Results were expressed as percentage of BCB inhibition and 
calculated as follows: (Aβ-carotene after 180 min/A initial β-carotene) x 100 (AA%). 
 
2.7.6 Total polyphenolic content (TPC) 
 
Experimental section Chapter 2 
 
- 19 - 
 
TPC was determined according to the Folin-Ciocalteu method (Milella et al., 2014) by 
adding 75 µL of the diluted samples extract (in the blank 75 µL of methanol) to 425 µL of 
distilled water, 500 µL of Folin-Ciocalteu reagent and 500 µL of a sodium carbonate 
aqueous solution (10% w/v). The mixture was stirred and left in the dark at room 
temperature for 60 min then absorbance was measured at 723 nm. Gallic acid was used as 
reference standard and TPC was expressed as mg Gallic Acid Equivalents (mgGAE)/g of 
sample. All analyses were performed in triplicate and results expressed as mean ± standard 
deviation. 
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Chapter 3  
 
3.1 Introduction: Siparuna genus 
 
The genus Siparuna (Siparunaceae, formerly placed in Monimiaceae family) comprises 
about 150 species of shrubs, small trees or climbers that inhabit tropical regions of Mexico, 
West Indies, Central and South America (Renner et al., 1997). Various species have been 
used in traditional medicine for the treatment of gastrointestinal disorders, skin diseases, 
snakebites, fever, colds, headache and rheumatism (Leitao et al., 2000). In Latin America, 
Siparuna species are also used by traditional healers from different countries for some 
rituals or to treat malaria. 
Phytochemical studies were carried out previously on some Central American species of 
Siparuna concerning benzylisoquinoline alkaloids, terpenoids and ﬂavonoids (Leitao et al., 
1999; Jenett-Siems et al., 2003). Siparuna thecaphora (Poepp. et Endl.) A. DC. is an 
aromatic shrub or small tree with opposite, simple leaves and unisexual ﬂowers; the fruits 
are strong lemon scented, such that it is locally called ‘limoncillo’. Due to its highly 
variable morphology, a great number of synonyms are found in the literature (e.g. Siparuna 
nicaraguensis Hemsl., Siparuna andina (Tul.) A.DC. and Siparuna gilgiana Perkins). 
Some chemical studies of S. thechaphora have been done previously: alkaloids were 
isolated from the twigs (under the synonym S. nicaraguensis) (Gerard et al., 1986) and the 
roots (under the synonym S. gilgiana) (Chiu et al., 1982). However, except for the 
composition of the essential oil (Vila et al., 2002), there is no information concerning the 
composition of secondary metabolites of the leaves.  
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Figure 3.1: Siparuna thecaphora 
 
3.2 Plant material 
 
Leaves of S. thecaphora were collected in Puerto Napo, Ecuador in June 2007. The plant 
was identiﬁed at the Herbarium of Jardin Botanico de Quito, Quito, Ecuador, where a 
voucher specimen was deposited (number MO-256138). 
 
3.3 Extraction and isolation 
 
The dried and powdered leaves (310 g) of S. thecaphora were successively extracted for 48 
h with n-hexane, CHCl3, CHCl3-MeOH (9:1) and MeOH, by exhaustive maceration (3 X 
2L), to give 13.3, 7.4, 4.5 and 10.6 g of the respective residues.  
The CHCl3-MeOH extract (4.5 g) was subjected to CC over Sephadex LH-20 in MeOH to 
give eight major fractions (A-H) grouped by TLC. Fractions B (123 mg) and D (141 mg) 
were separately purified by reverse-phase high performance liquid chromatography (RP-
HPLC) with MeOH-H2O (2:3) as eluent to afford a new compound trans-thujane-1α,7-diol 
1-O-β-D-glucopyranoside (compound 1, 2.7 mg, tR = 24 min) from fraction B and 3,4-
dihydroxybenzaldehyde (compound 2, 8.4 mg, tR = 8 min) from fraction D, respectively. 
Fraction G (91 mg) was also purified by RP-HPLC with MeOH-H2O (4.5:5.5) as eluent to 
yield quercetin 3-O-β-D-glucopyranoside (compound 3, 8.4 mg, tR = 16 min). The MeOH 
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extract was partitioned between n-BuOH and H2O to afford an n-BuOH residue (2.7 g). The 
n-BuOH fraction (2.7 g) was submitted to a Sephadex LH-20 CC using MeOH as eluent to 
obtain six major fractions (A-F) grouped by TLC. Fractions C (118 mg) and E (34 mg) 
were purified by RP-HPLC with MeOH-H2O (4.5:5.5) as eluent to give rutin (compound 4, 
4.5 mg, tR = 17 min) from fraction C and quercetin 3-O-β-D-galactopyranoside (compound 
5, 8.5 mg, tR = 16 min) from fraction E, respectively. 
The structure of new compound 1 is show in Figure 3.2, the structure of the other 
compounds 2-4 are reported in Figure 3.3.  
 
3.4 New isolated compounds 
 
Trans-thujane-1α,7-diol 1-O-β-D-glucopyranoside (1).  
 
Yellow oil [α ]D  = -126 (c 0.05, MeOH); 
1
H NMR data (600 MHz, CD3OD, δ in ppm, J in 
Hz): 0.55 (1H, dd, J = 8.0 and 3.5 Hz, H-3a), 0.92 (3H, d, J = 6.5 Hz, Me-9), 0.95 (3H, d, J 
= 6.5 Hz, Me-10), 0.99 (1H, dd (C-2glc), 77.8 (C-3glc), 77.9 (C-5glc),  67.5 (C-7), 91.0 (C-
1), 100.2 (C-1glc).  HR-ESI-MS: m/z 333.1897, J = 5.0 and 3.5 Hz, H-3b), 1.28 (1H, dd, J 
= 8.0 and 5.0 Hz, H-2), 1.37 (1H, septet, J = 6.5 Hz, H-8),1.58 (1H, ddd, J = 16.0, 5.5 and 
5.5 Hz, H-6a), 1.60 (1H, ddd, J = 14.0, 8.5 and 5.5 Hz, H-5b), 1.63 (1H, ddd, J = 14.0, 5.5 
and 5.5 Hz, H-5a), 1.73 (1H, ddd, J = 16.0, 8.5 and 5.5 Hz, H-6b), 3.22 (1H, dd, J = 9.0 and 
8.0 Hz, H-2glc), 3.29 (1H, m, H-5glc), 3.31 (1H, t, J = 9.0 Hz, H-4glc), 3.40 (1H, t, J = 9.0 
Hz, H-3glc), 3.56 (2H, s, H2-7), 3.66 (1H, dd, J = 12.0 and 5.0 Hz, H-6aglc), 3.82 (1H, dd, 
J = 12.0 and 3.5 Hz, H-6bglc),  4.65 (1H, d, J = 8.0 Hz, H-1glc). 
13
C  NMR (600 MHz, 
CD3OD, δ in ppm, J in Hz): 12.8 (C-3), 19.8 (C-9), 19.9 (C-10), 25.4 (C-5), 26.6 (C-2), 29.9 
(C-6), 33.4 (C-4), 33.7 (C-8), 62.7 (C-6glc), 71.5 (C-4glc), 75.0 (C-2glc), 77.8 (C-3glc), 
77.9 (C-5glc),  67.5 (C-7), 91.0 (C-1), 100.2 (C-1glc).  HR-ESI-MS: m/z 333.1897 [M + 
H]
+ (calcd for C16H29O7,  333.1913); ESI-MS: m/z 355 [M + Na]
+
 , 193 [M + Na - 162]
+
. 
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Figure 3.2: New isolated compound from S. thecaphora 
 
3.5 Structural elucidation 
 
As described before chromatographic separation of chloroform-methanol and methanol 
extracts of S. thecaphora leaves led to the isolation of one new monoterpene glycoside (1) 
(Figure 3.2) and four known compounds, namely 3,4-dihydroxybenzaldehyde (2) 
(Malarczyk et al., 1994),  quercetin 3-O-β-D-glucopyranoside (3), quercetin 3-O-β-D-
galactopyranoside (5) and rutin (4) (Agrawal, 1989). The structures of all the known 
compounds were determined by spectral analysis and comparison of data with those 
reported in the literature. 
Compound 1, a yellow oil, showed a quasi molecular ion peak at m/z 355 [M+Na]
+
 in the 
positive ESI-MS spectrum. The molecular formula was established to be C16H28O7 by HR-
ESI-MS and 
13
C NMR analyses. In the MS
2
 spectrum, a prominent fragment at m/z 193 
[M + Na - 162]
+
 was observed, due to the loss of one hexose residue. Its 
1
H NMR 
spectrum showed the presence of a monoterpene structure (Jakupovic et al., 1991) with 
two methyl doublets [δ 0.92 and (d, J = 6.5 Hz)] one hydroxymethylene group (δ 3.56, 
s), three methylenes (one of them was considered to be a methylene of a cyclopropane 
ring at δ 0.55, dd, J = 5.0 and 3.5 Hz), two methines and protons ascribable to a 
monosaccharide group. The 
13
C NMR of 1 revealed the presence of two methyls (δ 
19.8 and 19.9), four methylenes, of wich one was oxygenated (δ 12.8, 25.4, 29.9 and 
67.5), two quaternary carbons (δ 33.4 and 91.0) and characteristics signals of a β-
glucopyranosyl group (δ 62.7, 71.5, 75.0, 77.8, 77.9 and 100.2). Assignments of all 
chemical shifts of protons and carbons were ascertained from a combination of 1D total 
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correlation spectroscopy (TOCSY), double-quantum filtered correlated spectroscopy 
(DQF- COSY), heteronuclear single quantum coherence (HSQC) analysis (Sanogo et 
al., 1998). Direct evidence of the substituent sites was derived from the HSQC and 
heteronuclear multiple bond coherence (HMBC) data. The HMBC correlations 
between the proton signal at δ 3.56 (H2-7) and the carbon resonances at δ 26.6 (C-2), 
29.9 (C-6) and 91.0 (C-1); between the proton signal at δ  1.73 (H-6b) and the carbon 
resonances at δ 26.6 (C-2), 33.4 (C-4), 67.5(C-7) and 91.0 (C-1); between the proton 
signal at δ 1.28 (H-2) and the carbon resonances at δ 33.4 (C-4) and 67.5 (C-7)and 
between the proton signal at δ 0.99 (H-3b) and the carbon resonances at δ 25.4 (C-5), 
33.7 (C-8) and 91.0 (C-1) substantiated the presence of hydroxyl groups at C-1 and C-
7, while correlations between δ 4.65 (H-1glc) and 91.0 (C-1) confirmed the position of 
the glucopyranosyl moiety. The configuration of the glucopyranosyl moiety was 
determined to be D by hydrolysis of 1, trimethylsilysation and gas chromatography 
(GC) analysis. The relative stereochemistry of 1 was ascertained by 2D rotating frame 
Overhauser effect spectroscopy experiment. Rotating Overhauser effect correlations 
were observed between H-1glc and H-2 and between Me-10 and H-2 and H-3a. On the 
basis of all NMR evidences, the structures of 1 were determined as thujane-1α, 7-diol 1-
O-β-D-glucopyranoside. 
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Figure 3.3: Structures of known compounds from S. thecaphora 
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Chapter 4  
 
4.1 Introduction: Clinopodium genus 
 
The genus Clinopodium (Lamiaceae) consists of flowering plants, wildly distributed in 
southern and southeastern Europe, in the North America and Mexico (Estrada-Reyes et al., 
2010). It is also found growing in Latin America between 3000 and 4000 m a.s.l. Many 
species of the genus are used as medicinal plants. Clinopodium tomentosum (Kunth) 
Govaerts (Figure 4.1) possesses small yellow-colored ﬂowers, reaching a height of 30–80 
cm and in Ecuador is commonly known as “Santa Maria”. Local people use the aerial parts 
of the plant to prepare infusions for its relaxant effect and as anti-inflammatory agent. 
Previous phytochemical studies on Clinopodium ssp. have revealed the presence of 
ﬂavonoid glycosides, phenylpropanoids, caffeic acid oligomers, and saponins (Miyase and 
Matsushima, 1997; Opalchenova and Obreshkova, 1999; Murata et al., 2009; Aoshima et 
al., 2012). Despite its use in the Ecuadorian traditional medicine, to our knowledge, no data 
on the chemical composition or biological activity of the aerial parts of C. tomentosum are 
available. Nevertheless, its essential oil composition was reported by Benzo et al. in 2007. 
Next we reported the isolation and structural characterization by spectroscopic and 
spectrometric methods of one new compound, named 2-O-benzoyl-3-O-cinnamoyl tartaric 
acid (1) (Figure 4.2) along with twelve known compounds, from the aerial parts of the title 
plant. 
 
Figure 4.1: Clinopodium tomentosum 
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4.2 Plant material 
 
Aerial parts of C. tomentosum were collected in Tumbaco, Ecuador in September 2011. The 
plant was identiﬁed at the Herbarium of Jardin Botanico de Quito, Quito, Ecuador. A 
voucher specimen (N. 7305 Clinopodium tomentosum/1) was deposited at Herbarium Horti 
Botanici Pisani, Pisa, Italy. 
 
4.3 Extraction and isolation 
 
The dried and powdered aerial parts (560 g) of C. tomentosum were in sequence extracted 
for 48 h with n-hexane, CHCl3, CHCl3-MeOH (9:1) and MeOH, by exhaustive maceration 
(3 x 2 L), to give 7.6, 18.0, 8.5 and 13.1 g of the respective residues. The CHCl3-MeOH 
extract (2.5 g) was subjected to Sephadex LH-20 (CC, 3 x 70 cm, flow rate 1.5 mL/min) 
eluting with MeOH to give six major fractions (A-F) grouped by TLC, together with pure 
caffeic acid (compound 2, 50 mg, 370-420 mL) and hesperitin (compound 3, 40 mg, 560-
1000 mL). Fractions C (328 mg), D (904 mg), and E (157.8 mg) were separately purified 
by RP-HPLC with MeOH-H2O (2:3) as eluent to afford blumenol c glucoside (compound 
4, 5.3 mg, tR = 17 min) from C, syringaresinol 4’-O-β-D-glucopyranoside (compound 5, 8.6 
mg, tR = 17 min) and dihydrodehydroconiferyl alchol 9’-O-β-D-glucopyranoside 
(compound 6, 10 mg, tR = 19 min) from D, and p-coumaric acid (compound 7, 6 mg, tR = 
16 min), caffeic acid methyl ester (compound 8, 10 mg, tR = 24 min) and caffeic acid ethyl 
ester (compound 9,7.7mg, tR = 42 min) from E. The MeOH extract was partitioned between 
n-BuOH and H2O to afford a n-BuOH residue (6.2 g). The n-BuOH fraction (6.2 g) was 
submitted to Sephadex LH-20 (CC, 5 x 70 cm, flow rate 1.5 mL/min) using MeOH as 
eluent to obtain seven major fractions (A-G) grouped by TLC, together with pure caffeic 
acid (compound 2, 14.2 mg, 260-270 mL) and clinopodic acid E (compound 10, 62.4 mg, 
550-590 mL). Fractions D (135.5 mg) and E (243 mg) were separated by RP-HPLC with 
MeOH-H2O (2:3) as eluent to give compound 1 (5.7 mg, tR = 22 min) from fraction D, and 
rosmarinic acid (compound 11, 20 mg, tR = 18 min) and rosmarinic acid methyl ester 
(compound 12, 7 mg, tR = 41 min) from fraction E, respectively. Fraction C (443 mg) was 
Phytochemical studies Chapter 4 
 
- 28 - 
 
previously submitted to partition between n-BuOH and H2O yielding a n-BuOH residue 
(67.8 mg) which was subsequently subjected to RP-HPLC with MeOH-H2O (1:1) as eluent 
to yield pinocembrin 7-rutinoside (compound 13, 2 mg, tR = 15 min). Fraction F (330 mg) 
was purified by RP-HPLC with MeOH-H2O (1:1) as eluent to give rosmarinic acid 
(compound 11, 10 mg, tR = 9 min) and hesperetin (compound 3, 5 mg, tR = 24 min). 
The structures of compounds 2-13 are showed in Figures 4.3, 4.4 and 4.5 
 
4.4 New isolated compound 
 
2-O-Benzoyl-3-O-cinnamoyl tartaric acid (1) 
Amorphous powder; [ ]25Da  -70 (c 0.2, MeOH); UV (MeOH) max/nm (log ) 213 (4.20), 225 
(3.82), 309 sh (4.10); HR-ESI-MS m/z, calcd. for C20H16O8Na [M+Na]
+
: 407.0743, found: 
407.1691, 277.2327 [M+Na-130]
+
, 131.3031 [M+Na-130-146]
+
; ESI-MS m/z, 383 [M-H]
-
; 
1
H NMR (600 MHz, CD3OD) and 
13
C NMR (150 MHz, CD3OD) data see Table 4.1. 
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Figure 4.2: Structure of compound 1 
 
4.5 Structural elucidation 
 
The chloroform-methanol and the methanol extracts of the aerial parts of C. tomentosum 
were subjected to Sephadex LH-20 column chromatography followed by reverse phase 
high performance liquid chromatography (RP-HPLC), to afford one new compound (1) 
(Figure 4.1) and twelve known compounds (2-13) (Figure 4.3-4.5).  
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Compound 1 was isolated as amorphous solid. Its molecular formula was determined as 
C20H16O8 by HR-ESI-MS (m/z 407.1691 [M+Na]
+
). Its HR-ESI-MS/MS spectrum showed 
two main fragments at m/z 277.2327 [M+Na-130 (C9H6O)]
+
 (95%) and 131.3031 [M+Na-
130 (C9H6O)-146 (C9H6O2)]
+
 (28%) due to the loss of two asymmetric ester moieties. The 
1
H and 
13
C NMR spectra (Table 4.1) showed typical signals of a trans-double bond 
together with other five aromatic [δH 7.45 (3H, overlapped, H-3''/5'' and H-4''), 7.50 (2H, t, 
J 7.5, H-3'/5'), 7.62 (1H, overlapped, H-4'), 7.65 (2H, overlapped, H-2''/6''), 8.17 (2H, t, dd, 
J 7.5, 1.5, H-2'/6')] and two hydroxymethines signals at δH 5.80 (1H, d, J 2.7) and 5.82 (1H, 
d, J 2.7). This information in conjuction with the remaining NMR signals and HR-ESI-
MS/MS spectra, indicated the presence of a tartaric acid esterified with one benzoyl and 
one cinnamoyl residues. All the 
1
H and 
13
C NMR signals were assigned with the aid of 2D 
NMR spectra including 1D-TOCSY, DQF-COSY, HSQC, and HMBC spectra. The 
downfield shift of H-2 and H-3 (δ 5.80 and 5.82) and C-2 and C-3 (both 76.0 ppm) 
compared to tartaric acid confirmed that these positions were esterified (Soicke et al., 
1988). The configuration of C-2 and C-3 remained undetermined. On the basis of all these 
evidences the structure of 1 was determined as 2-O-benzoyl-3-O-cinnamoyl tartaric acid. 
Asymmetric esters of tartaric acid are found rarely in nature, being isolated mostly from 
Echinacea genus (Soicke et al., 1988; Lu et al., 2012).
 
The following known compounds were identified by spectral analysis and comparison with 
published spectroscopic data: caffeic acid (2), caffeic acid methyl ester (8) (Saleem et al., 
2004) hesperitin (3) (Wagner et al., 1976), blumenol c glucoside (4) (Pabst et al.,1992),
 
syringaresinol 4’-O-β-D-glucopiranoside (5) (Shahat et al., 2004), dihydrodehydroconiferyl 
alchol 9’-O-β-D-glucopyranoside (6) (Abe and Yamauchi, 1986), p-coumaric acid (7) 
(Ralph et al., 1994), caffeic acid ethyl ester (9) (Sugiura et al., 1989), clinopodic acid E 
(10) (Murata et al., 2009), rosmarinic acid (11), rosmarinic acid methyl ester (12) (Eicher et 
al., 1996) and pinocembrin 7-rutinoside (13) (Xu et al., 2011).
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Figure 4.3: Structures of known compounds from C. tomentosum 
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Figure 4.4: Structures of compounds 7 to 10 from C. tomentosum 
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Figure 4.5: Structures of compounds 11-13 from C. tomentosum 
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Table 4.1. 
1
H NMR (600 MHz) and 
13
C NMR (150 MHz) data of compound 1 (CD3OD)
a
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a 
chemical shifts are given in ppm; assignments were confirmed  
by DQF-COSY, 1D-TOCSY, HSQC, and HMBC experiments 
o
 overlapped signals 
 
 
 
 
 
 
 
 
 
 
Position δH (J/Hz) δC 
1/4  173.0 
2 5.80 d (2.7) 76.0 
3 5.82 d (2.7) 76.0 
Benzoyl 1'  128.5 
2'/6' 8.17 dd (7.5, 1.5) 133.6 
3'/5' 7.50 t (7.5) 129.1 
4' 7.62
o
 133.6 
COO  167.2 
Cinnamoyl 1'  134.3 
2''/6'' 7.65
o
 128.8 
3''/5'' 7.45
o
 130.0 
4'' 7.45
o
 130.0 
7'' 7.80 d (16.0) 146.2 
8'' 6.71 d (16.0) 118.4 
9''COO  167.2 
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Chapter 5  
 
4.1 Introduction: Euphorbia genus 
 
Euphorbia genus belongs to Euphorbiaceae family and contains at least 2000 species. It’s 
considered as one of the most diverse group of flowering plants on the earth. The species of 
this genus are known for their abundant content of diterpenes, which have wide biological 
activity, since they demonstrated antitumoral, antiviral and antifungal properties (Avila et 
al., 2010). Diterpenes, as main secondary metabolites of these plants, have provided many 
lead compounds for drug development due to their structural diversity including polycyclic 
and macrocyclic skeletons and various aliphatic and aromatic ester groups (Faiella et al., 
2012).  
All the species of Euphorbia genus produce white latex that they exude when cut, and this 
sap is demonstrated to be often toxic. Even if there are many herbaceous plants, the most 
part of the species seems to be succulent; some of them appear very similar to cacti.    
The flowers, male or female, are unisexual, putted together into a cluster known as 
“cyathium”, that is a particular characteristic of the genus. The cyathium features show 
modifications within the different groups of plants. The fruit is a capsule, about 8-12 mm, 
that normally split open when ripe and potentially contains three seeds (Motta, 1960). 
Many species of the genus have been used in folk medicine as anti-inflammatory, 
analgesic, antipyretic agents, for treatment of cancer, diarrhea, warts and skin diseases. 
(Mwine and Van Damme, 2011; Avila et al., 2010). 
Euphorbia laurifolia Juss. ex Lam. (Figure 5.1) is wildly distributed in Colombia, 
Venezuela, Ecuador, Peru and Bolivia. In Ecuador is easily found all over the provinces of 
the Andes, from 1500 up to 3000 meters above sea level. It corresponds to a glabrous 
shrub, 2-6 meters high, with stout branches, apically foliate and axillary cymes. The upper 
peduncles have 3 heads; leaves crowed, shortly petioled, oblanceolated- oblong, entire, 1-
1.5 dm long, 2-3 cm wide, at least the lower more or less spreading-deflexed. With green 
cyathia, 5 mm long and wide, glands fleshy, 1-1.5 mm long, 3.5 wide, hirsute without, 
Phytochemical studies Chapter 5 
 
- 34 - 
 
otherwise glabrous. The stamens correspond to 25-30 filaments, 4 mm long, yellow 
anthers, 1-1.5 mm long and lacerate-hirsute bracts, 2-5 mm long (Macbride, 1951). 
The wood is use as raw material for homebuilding, the milky sap or latex is suggested to 
have a protective and defensive role in helping heal wounds and in deterring potential 
plant-eaters. There is not too much information reported about the uses of this species, but 
leaves and latex seem to be used as infusion for cough (Tene et al., 2007). The plant is also 
used as living fences and as ornamental in some parks of Quito. 
 
 
Figure 5.1 Euphorbia laurifolia Juss. ex 
 
4.2 Plant material 
 
Aerial parts of E. laurifolia were collected in Tumbaco, Ecuador in September 2011. The 
plant was identiﬁed at the Herbarium of Jardin Botanico de Quito, Quito, Ecuador. A 
voucher specimen (N. 4498 Euphorbia laurifolia/1) was deposited at Herbarium Horti 
Botanici Pisani, Pisa, Italy. 
 
4.3 Extraction and isolation 
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The dried powdered leaves of E. laurifolia (527 g) were successively extracted for 48 h 
with n-hexane, CHCl3, CHCl3-MeOH (9:1) and MeOH, by exhaustive maceration (3 x 2L), 
to give 15.2, 14.6, 2.7 and 20.2 g of the respective residues. The n-hexane extract (15.2 g) 
was partitioned between n-hexane and MeOH-H2O (3:2), to afford a polar fraction (0.473 
g) that was chromatographed over silica gel column using Biotage
®
 Isolera
™
 Spektra flash 
purification system, eluting with n-hexane-CHCl3 (1:1) follow by increasing concentrations 
of CHCl3 in n-hexane (between 50 % and 100%), then by increasing concentrations of 
MeOH in CHCl3  (between 3% and 10%). Fractions of 12 ml were collected, analyzed by 
TLC (silica gel plates, in mixture of  n-hexane-CHCl3 1:1, CHCl3 and mixtures of CHCl3-
MeOH 98:2, 95:5, 9:1), and grouped into 3 major fractions (A-C). Fraction B (295.6 mg) 
was purified by HPCPC (High Performance Centrifugal Partition Chromatography) with n-
hexane-AcOEt-MeOh:H2O (8:5:5:2), in which the stationary phase consisted of the upper 
phase (descending mode, flow rate of stationary phase 10 ml/min and of mobile phase 3 
ml/min); 155 tubes were collected that give three major fractions (A-C) grouped by TLC. 
Fraction B (20.2 mg), was purified by RP-HPLC with MeOH-H2O (7.5:2.5) as eluent to 
afford  a new diterpene 7,8,15-triacetoxy-3-(2-methylpropanoyloxy)-4,9H,11H-
lathyra-5E,12E-dien-14-one (compound 1, 0.5 mg, tR = 10 min) and latazienone (compound 
2, 0.7 mg, tR = 8 min). 
Part of the CHCl3 extract (5 g) was chromatographed over silica gel column using Biotage
®
 
Isolera
™
 Spektra flash purification system, eluting with n-hexane-CHCl3 (1:1) followed by 
increasing concentrations of CHCl3 in n-hexane (between 50 % and 100%), then by 
increasing concentrations of MeOH in CHCl3  (between 5% and 20%). Fractions of 27 ml 
were collected, analyzed by TLC (silica gel plates, in mixture of  n-hexane-CHCl3 7:3, 8:2, 
CHCl3 and mixtures of CHCl3-MeOH 99:1, 98:2, 97:3, 95:5, 9:1, 85:15), then grouped into 
10 major fractions (A-J). Fraction D (186 mg) was subjected to RP-HPLC with MeOH-
H2O (5.5:4.5) as eluent to give isofraxidin (compound 3, 18 mg, tR = 11 min). Fraction E 
(486 mg) was purified by RP-HPLC with MeOH-H2O (8.5:1.5) as eluent to give another  
new diterpene, 2-hydroxy-ent-abieta-8,13-dien-12,16-olide  (compound 4, 1.5 mg, tR = 7 
min). Fraction F (180.5 mg) was purified over RP-HPLC with MeOH-H2O (7:3) as eluent 
yield ent-16α,17-dihydroxykauran-3-one (compound 5, 2.2 mg, tR = 12 min). Fraction G 
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(485.6 mg) was subjected to RP-HPLC with MeOH-H2O (6.5:3.5) as eluent to give 
vomifoliol (compound 6, 3.1 mg, tR = 6 min) and another pure known compound ent-16α, 
17-dihydroxyatisan-3-one (compound 7, 1.3 mg, tR = 17 min). Fraction H (220.9 mg) was 
purified over RP-HPLC with MeOH-H2O (2:3) as eluent to give p-hydroxy phenylethyl 
alcohol (compound 8, 3.6 mg, tR = 12 min) and a new abietanolide 6,9,13-trihydroxy-
megastigman-7-en-3-one (compound 9, 2.5 mg, tR = 24 min). Fraction I (190.9 mg) was 
subjected to RP-HPLC with MeOH-H2O (5.5:4.5) as eluent to yield another new diterpene 
18-hydroxy-9H,11H-lathyra-4(15),5(6)-dien-1,14-dione-18--D-glucopyranoside 
(compound 10, 7.8 mg, tR = 13 min). 
The CHCl3-MeOH extract (2.7 g) was chromatographed over Sephadex LH-20 to give 5 
major fractions (A-E) grouped by TLC. Fraction B (449 mg) was purified over RP-HPLC 
with MeOH-H2O (1:1) as eluent to give corchoinoside c (compound 11, 3.1 mg, tR = 7 min) 
and compound 10 (7.4 mg, tR = 16 min). Fraction C (475 mg) was subjected to RP-HPLC 
with MeOH-H2O (1:4) as eluent to yield compound 8 (2.5 mg, tR = 13 min) and scopoletin 
(compound 12, 1.6 mg, tR = 34 min). 
The MeOH extract (20.1 g) of E. laurifolia was partitioned between n-BuOH and H2O, to 
afford a n-BuOH residue (2.9 g). The n-BuOH fraction was submitted to Sephadex LH-20 
using MeOH as eluent to obtain eight major fractions (A-H) grouped by TLC.  Faction G 
results into a pure compound, quercetin 3-O-β-D-glucuronopyranoside (compound 13, 35.5 
mg). Fraction B (407.4 mg) was purified over RP-HPLC with MeOH:H2O (4.5:5.5) as 
eluent to give compound 10 (1.6 mg, tR = 13 min), corchoinoside c (compound 11, 2.5 mg, 
tR = 7 min), as well as the new compounds, 18-hydroxy-9H,11H-lathyra-4(15),5(6)-
dien-1,14-dione-18--D-glucopyranoside (compound 14, 1.2 mg, tR = 60 min), and 20-
deoxy-16-hydroxyingenol-3--D glucopyranoside (compound 15, 1.1 mg, tR = 23 min). 
Fraction D (364.6 mg) was purified by RP-HPLC with MeOH-H2O (3:7) as eluent to yield 
chlorogenic acid (compound 16, 1.4 mg, tR = 15 min), caffeic acid (compound 17, 1.8 mg, 
tR = 11 min), 4-O-caffeoyl quinic acid (compound 18, 2.1 mg, tR = 25 min),  4-O-caffeoyl 
quinic acid methyl ester (compound 19, 1.2 mg, tR = 40 min) and scopoletin (compound 12, 
2.1 mg, tR = 65 min). 
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Fraction F (452.2 mg) was subjected to RP-HPLC with MeOH-H2O (2:3) as eluent to give 
kaempferol 3-O-β-D-glucuronopyranoside (compound 20, 10 mg, tR = 30 min). 
The structures of the new compounds are shown in Figure 5.2. The structures of the other 
compounds are reported in Figure 5.3. 
 
4.4 New isolated compounds 
 
7,8,15-triacetoxy-3-(2-methylpropanoyloxy)-4,9H,11H-lathyra-5E,12E-dien-14-
one (1) 
Pale yellow oil; 
1
H and 
13
C NMR data, see Table 5.2; HR ESIMS m/z 569.2344 [M+Na]
+
 
(calcd for C30H42O9 546.2829), 509.2666 [M+Na-60]
+
, 449.3008 [M+Na-60-60]
+
, 389.3351 
[M+Na-60-60-60]
+
. 
 
2-hydroxy-ent-abieta-8,13-dien-12,16-olide (4)  
Amorphous powder; 
1
H and 
13
C NMR data, see Table 5.3; HR ESIMS m/z 339.2778 
[M+Na]
+
 (calcd for C20H28O3 316.2038), 317.2920 [M+H]
+
. 
 
6,9,13-trihydroxy-megastigman-7-en-3-one (9) 
Amorphous powder;  25D  +8 (c 0.125, MeOH); 
1
H and 
13
C NMR data, see Table 5.3; HR 
ESIMS m/z 507.3278 [2M+Na]
+
 (calcd for C13H22O4 242.1518). 
 
18-hydroxy-9H,11H-lathyra-4(15),5(6)-dien-1,14-dione-18--D-glucopyranoside (10) 
Pale yellow oil;  25D  +19 (c 0.1, MeOH); UV (MeOH) max (log e): 245 (3.90), 230 sh; 
1
H 
and 
13
C NMR data, see Table 5.1; ESI-MS m/z 477 [M-H]
-
, 315 [M-H-162]
-
; HR ESIMS 
m/z 501.2439 [M+Na]
+
 (calcd for C26H38O8 478.2567), 347.3342 [M-H-162]
-
, 329.3456 
[M-H-162-18]
-
. 
 
18-hydroxy-9H,11H-lathyra-4(15),5(6)-dien-1,14-dione-18--D-glucopyranoside (14)  
Phytochemical studies Chapter 5 
 
- 38 - 
 
Pale yellow oil; 
1
H and 
13
C NMR data, see Table 5.1; ESI-MS m/z 477 [M-H]
-
; HR ESIMS 
m/z 501.2439 [M+Na]
+
 (calcd for C26H38O8 478.2567). 
 
20-deoxy-16-hydroxyingenol-3--D glucopyranoside (15) 
pale yellow oil; 
1
H and 
13
C NMR data, see Table 5.2; HR ESIMS m/z 509.2432 [M-H]- 
(calcd for C26H38O10 510.2465), 347.3342 [M-H-162]
-
, 329.3456 [M-H-162-18], 533.2091 
[M+Na]
+
, 353.3166 [M+Na-180]
+
. 
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Figure 5.2: New isolated compounds from E. laurifolia 
 
4.5 Structural elucidation and biological activity  
 
The structures of all the following known compounds were determined by spectral analysis 
and comparison of data with those reported in the literature: latazienone (2) (Rondon et al., 
2005), isofraxidin (3) (Borris et al., 1980), ent-16α,17-dihydroxykauran-3-one (5) (Ding 
and Jia, 1991), vomifoliol (6) and corchoinoside c (11) (Calis et al., 2002), ent-16α, 17-
dihydroxyatisan-3-one (7) (Lal et al., 1990), p-hydroxy phenylethyl alcohol (8), scopoletin 
(12) (Tsukamoto et al., 1984), quercetin 3-O -β-D-glucuronopyranoside (13) (Parejo et al., 
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2004), chlorogenic acid (16), caffeic acid (17) (Saleem et al., 2004), 4-O-caffeoyl quinic 
acid (18), 4-O-caffeoyl quinic acid methyl ester (19) (Zhu et al., 2005) and kaempferol 3-O 
-β-D-glucuronopyranoside (20) (Merfort and Wendisch, 1998). 
The 
13
C NMR spectrum of 15 showed 26 carbon atoms which can be recognized as four 
methyls, three methylenes, thirteen methynes, and six quaternary carbons. Moreover, the 
analysis of 
13
C NMR chemical shifts showed the presence of a carbonyl, eleven oxygen-
bearing carbon atoms and four sp
2
 carbons. The molecular formula C26H38O10 was 
established for 15 from 
13
C NMR data and the HRESIMS spectrum (m/z 509.2432 [M-H]
-
). 
The analysis of fragmentation pattern in the HRESIMS/MS experiment showed peaks at 
m/z 347.3342 [M-H-162]
-
 and 329.3456 [M-H-162-18]
-
 suggesting the presence of one 
hexose unit. The 
1
H NMR aglycone portion spectrum of 15 revealed the presence of two 
olefinic protons at δ 5.70 (1H, br d, J = 4.0 Hz) and 5.88 (1H, s), two methyl groups bearing 
a double bond at δ 1.77 (3H, s) and 1.87 (3H, s), two hydroxymethynes at δ 3.34 and 3.31, 
as overlapped signal, and 4.50 (1H, s), and one hydroxymethyne at δ 3.70 and 3.71 (each 
1H, d, J = 11.0 Hz). Additionally, two methynes at δ 0.84 (1H, br t, J = 8.5, 4.2 Hz) and 
0.95 (overlapped signal) attributable to a cyclopropane ring were evident. The DQF-COSY 
and 1D-TOCSY spectra of 15 showed one main spin system from Me-18 to H-7. The 
interpretation of HSQC results permit to associate all the proton chemical shifts to those of 
the respective carbon resonances; then, the study of HMBC cross peaks was used to link the 
previous obtained spin system to the quaternary carbons, indicating that 15 was an ingenol 
derivative (Marco et al., 1997) The chemical shifts of H-3 showed correlations with C-1, C-
2, C-4, C-5, and C-10; H-7 with C-8, C-9 and Me-20; H-11 with C-9, C-10, C-13, and Me-
18. Correlations of Me-20 with C-5, C-6, and C-9 and Me-16 with C-13, C-15, and C-17 
led to establish the remaining structural connectivities. The position of the sugar moiety 
was ascertained to be at C-3 from the HMBC cross peak between H-1glc (δ 4.52) and C-3 
(90.0 ppm). The relative stereochemistry of the stereogenic centers was partially 
determined from the cross peaks observed in the ROESY spectrum. Key correlations peaks 
were pointed out between H-8 and H-11, and H2-17; H-3 and H-5; H-11 and H2-17 and 
were in agreement with the relative stereochemistry reported in the literature for similar 
compound (Marco et al., 1997; Bakhsh Baloch et al., 2009). The configuration of the 
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glucopyranosyl moiety was determined to be D by hydrolysis, trimethylsilylation, and GC 
analysis. Consequently, the obtained data led to establish compound 15 as 20-deoxy-16-
hydroxyingenol-3--D glucopyranoside. 
Compounds 10 and 14 were obtained as yellow oils. Their HRESIMS exhibited a 
molecular ion peak at m/z 501.2439 [M+Na]
+
 for 10 and 501.2437 [M+Na]
+
 for 14, 
respectively, which agreed with the molecular formula C26H38O8, showing that they were 
two isomers. Another product ion detected in their HRESIMS spectra at m/z 317.2104 
[M+H-162]
+
 and 317.2101 [M+H-162]
+
 was strongly suggestive of the presence of one 
hexose unit. The 
1
H NMR, 
13
C NMR (Table 5.1), and 
13
C DEPT spectra of 10 indicated, 
besides signals attributable to one sugar moiety, the presence of two ketone groups, two 
double bonds (one trisubstituted and one tetrasubstituted), and 14 sp
3
 carbons, including 
four methyls, five methylenes, four methynes, and one quaternary carbon. These 
observations were confirmed by the presence in the 
1
H NMR spectrum of signals at 5.71 
(1H, s) and  1.68 (3H, s); characteristic signals at  0.56 (1H, br t, J = 9.0 Hz) and 0.77 
(1H, ddd, J = 13.0, 8.0, 3.0 Hz) suggested a cyclopropane ring, present in many types of 
diterpenes from Euphorbiaceae genus (Liao et al., 2005). DQF-COSY, 1D-TOCSY and 
HSQC experiments of 10 allowed to establish the following connectivities: H-2─H-3 for 
ring A, H-7─H-20 for ring B, which led to recognize the structural moieties of a lathyrane 
diterpene (Rondon et al., 2005). Analysis of the chemical shifts, signal multiplicities, and 
absolute values of the coupling constants in the 
1
H NMR spectrum, as well as 
13
C NMR 
data, indicated the presence of one glucopyranosyl moiety with a β-configuration at the 
anomeric carbon. The configuration of the glucopyranosyl moiety was determined as 
reported for 15. The chemical shift assignments of the carbon atoms of 10 were established 
from the HSQC and HMBC spectra. Key HMBC correlations between H2-3C-1, H2-
3C-4, H2-3C-15; H2-7C-5, H2-7C-9, H2-7C-11, H2-7C-17; H-9C-7, H-
9C-10, H-9C-18; H-11C-9, H-11C-13; Me-16C-1, Me-16C-3; Me-17C-4, 
Me-17C-5, Me-17C-7; H2-18C-1glc; Me-20C-11, Me-20C-12, Me-20C-14, 
were observed and allowed to locate the keto groups at C-1 and C-14, the conjugated 
double bonds at C-4/C-15 and C-5/C-6, and the glucopyranosyl moiety at C-18. The NMR 
Phytochemical studies Chapter 5 
 
- 41 - 
 
spectra of 14 were almost superimposable with those of 10; differences were observed for 
the chemical shifts of C-2 ( 2.62 and 41.0 in 10 versus  2.58 and 41.0 in 14), C-3 (2.97 
and 2.53 and 37.2 in 10 versus  2.30 and 3.19 and 37.2 in 14), and C-16 ( 1.22 and 16.6 
in 10 versus  1.29 and 16.5 in 14). Therefore, it was possible to hypothesize that the 
stereochemistry at C-2 of A-ring in the two compounds was the point of difference. Thus, 
compounds 10 and 14 were elucidated as 18-hydroxy-9H,11H-lathyra-4(15),5(6)-dien-
1,14-dione-18--D-glucopyranoside. The absolute configuration of both compounds is still 
in progress.  
HRESIMS spectrum identified compound 1 as C30H42O9 with molecular ion peak at m/z 
569.2344 [M+Na]
+
. The analysis of MS spectrum and 
13
C NMR data showed ten degrees of 
unsaturation, seven of which attributable to four ester functionalities, two double bonds and 
one carbonyl group. Analysis of NMR spectral data evidenced that 1 was a tricyclic 
lathyrane diterpene. The study of NMR data for the diterpenoid core matched those for 
latazienone (Rondon et al., 2005) being the esterification substitution the point of 
difference. Compound 1 differed from latazienone only in the replacement of the benzoyl 
group at C-7 with an acetyl group. Therefore, 1 was elucidated as 7,8,15-triacetoxy-3-
(2-methylpropanoyloxy)-4,9H,11H-lathyra-5E,12E-dien-14-one. 
The molecular weight determined for compound 4 was 316 (HRESIMS at m/z 317.2920 
[M+H]
+
, C20H28O3). The 
1
H NMR spectrum of 4 revealed the presence of four methyls, one 
of which bearing a double bond, one olefinic proton, and two hydroxymethine. The 
13
C 
NMR spectrum displayed twenty signals including four sp
2
 carbons and one ester 
functionality; being the unsaturation degree seven, compound 4 was found to be tetracyclic. 
Analysis of DQF-COSY and HSQC experiments showed the fragments H-1H-3, H-
5H-7, and H-9H-12. The inspection of all NMR data revealed signals attributable to a 
helioscopinolide diterpene. The position of hydroxyl group at C-2 was based on the 
chemical shifts of C-1, C-2, and C-3 and the observed HMBC correlations between H-
1C-3, H-2C-10, H-3C-2; the relative stereochemistry of OH-2 was established as 2 
from the H-2 chemical shift ( 3.84) and coupling constant of H-1 (2.23, br d, J = 14.0 
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Hz, 1.08, dd, J = 14.0, 4.5 Hz) and H-2 ( 3.84, 1H, br dd, J = 4.5, 3.5 Hz). Thus, 4 was 
identified as 2-hydroxy-ent-abieta-8,13-dien-12,16-olide. 
Compound 9 was isolated as an amorphous powder and showed in the HRESIMS a peak at 
m/z 507.3278, which supported by NMR data, suggested the molecular formula to be 
C13H22O4. The 
1
H and 
13
C NMR spectra (Table 5.3) indicated that compound 9 was a 
megastigmane derivative with a carbonyl group at C-3, hydroxyl functional group at C-6 
and a disubstituted double bond. A resonance for a hydroxymethylene was also observed in 
the 
1
H NMR (H 3.85, dd, J = 10.5, 5.0 Hz, and H 3.61, dd, J = 10.5, 3.0 Hz) and in the 
13
C 
NMR (C 64.0). The elucidation of the whole skeleton from the above subunits was 
achieved on the basis of HSQC and HMBC correlations, which also allowed the 
assignment of all the resonance in the 
13
C NMR spectrum of the pertinent carbons. 
According to HMBC spectrum the hydroxymethylene protons showed a long range 
correlation with C-4 (C 41.5), C-5 (C 43.6), and C-6 (C 78.1), while the double bond 
proton at  5.80 (H-7) exhibited a long range correlation with C-6 and C-9 signals, 
indicating that hydromethylene function was located at C-5, while the double bond at 
carbons C-7 and C-8 (De Marino et al., 2004). The relative stereochemistry determination 
of compound 9 is still under progress but basing on literature data (De Marino et al., 2004) 
it can be supposed to be as reported in Figure 5.2. These findings suggested that the 
structure of 9 was 6,9,13-trihydroxy-megastigman-7-en-3-one. 
The antiproliferative activity of compound 10 was preliminary assayed against human 
prostate cancer (PC-3) and human breast adenocarcinoma (MCF7) cell lines, showing an 
IC50 value of 25 µM at 24 and 48 h. In order to identify compound 10 molecular target a 
DARTS method was performed. The LC-MS analyses following in-gel trypsin digestions 
led to the identification of the proteins reported below (Table 5.4). Clathrin heavy chain 1, 
that is involved in the internalization of exogenous compounds, appeared both in PC3 and 
MCF7 cell lines according with previous reports of lathyrane diterpenes (Reis et al., 2013). 
Moreover 10 seems to influence the synthesis and translocation of ATP and the acylCoA 
metabolism. More investigations will be carried out to confirm these preliminary results. 
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Figure 5.3: Structures of known compounds isolated from E. laurifolia 
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Table 5.1. 
1
H and 
13
C NMR Data of Compounds 10 and 14 (Methanol-d4, 600 MHz)
a 
 
a 
J values are in parentheses and reported in Hz; chemical shifts are given in ppm; assignments were 
confirmed by DQF-COSY, 1D-TOCSY, HSQC, and HMBC experiments. 
b
 overlapped signal. 
 
 
 
                           10                                    14  
position H C H C
1  213.4  213.2 
2 2.62 m 
 
 
 
2.10) 
 
40.9 2.58 m 
 
 
 
2.10) 
 
41.0 
3a 2.97 dd (14.0, 3.5) 37.2 3.19
b
 37.2 
3b 2.53 dd (14.0, 2.0)  2.30 dd (18.0, 16.0)  
4  169.3  169.5 
5 5.71 s 116.6 5.71 s 116.5 
6  145.9  145.4 
7a 2.37 m 39.4 2.36 m 39.4 
7b 2.25 br t (12.0)  2.22 br t (12.0)  
8a 1.89
b
 23.6 1.88
b
 23.5 
8b 1.18 m  1.18 m  
9 0.56 br t (9.0) 26.2 0.55 br t (9.2) 26.1 
10  21.7  21.7 
11 0.77 ddd (13.0, 8.0, 3.0) 22.7 0.76 ddd (13.5, 9.0, 5.0) 21.4 
12a 1.89
b
 27.5 1.88
b
 27.4 
12b 1.40 ddd (15.0, 8.0, 3.0)  1.40 ddd (15.0, 7.5, 3.0)  
13 3.32
b
  44.6 3.33
b
 44.2 
14  211.4  211.4 
15  142.0  142.0 
16 1.22 d (6.5) 16.6 1.29 d (6.5) 16.5 
17 1.68 s 20.7 1.66 s 20.6 
18a 3.59 d (11.0) 80.4 3.58 d (11.0) 80.4 
18b 3.40 d (11.0)  3.39 d (11.0)  
19 1.02 s 11.5 1.02 s 11.0 
20 1.07 d (6.5) 17.3 1.08 d (6.5) 17.9 
Glc 1' 4.31 d (7.5) 103.6 4.31 d (7.5) 103.2 
2' 3.22 dd (9.0, 7.5) 75.0 3.21 dd (9.0, 7.5) 74.7 
3' 3.29 t (9.0) 77.6 3.27 t (9.0) 77.7 
4' 3.34 t (9.0) 71.3 3.34 t (9.0) 71.4 
5' 3.37 m 78.0 3.34 m 78.0 
6'a 3.88 dd (12.0, 3.5) 62.5 3.88 dd (12.0, 3.0) 62.3 
6'b 3.71 dd (12.0, 5.0)  3.72 dd (12.0, 4.5)  
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Table 5.2. 
1
H and 
13
C NMR Data of Compounds 1 and 15 (Methanol-d4, 600 MHz) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a 
J values are in parentheses and reported in Hz; chemical shifts are given in ppm;  
assignments were confirmed by DQF-COSY, 1D-TOCSY, HSQC, and HMBC experiments.  
b
 overlapped signal. 
 
 
 
 
 
 
 
 
 15  1  
position H C H C
1a 5.88 s 131.0 2.81 dd (15.0, 6.2) 42.2 
1b   2.19 dd (15.0, 7.8)  
2  
 
 
 
2.10) 
 
140.0 2.32 m 
 
 
 
2.10) 
 
39.0 
3 4.50 s 90.0 4.85b 83.0 
4 87.6 2.84 dd (6.2, 3.4) 47.8 
5 3.34b 76.4 5.85 d (10.7) 124.6 
6  140.6  140.8 
7 5.70 br d (4.0) 123.6 4.88b 77.8 
8a 4.38 br d (11.0)  44.4 5.29 br t (10.5) 73.8 
8b   1.18 m  
9  211.0 1.43 br t (8.5) 34.6 
10  73.6  26.4 
11 2.44 m 40.6 1.80 dd (12.0, 8.5) 30.7 
12   6.66 d (12.0) 145.6 
12a 2.40 m 31.3   
12b 1.86
b    
13 0.84 br t (8.5, 4.2) 24.6  134.3 
14 0.95b 24.0  195.8 
15  31.0  96.0 
16 1.14 s 24.6 1.05 d (6.5) 18.4 
17   1.61 s 18.2 
17a 3.71 d (11.0) 62.8   
17b 3.70 d (11.0)    
18 0.95 d (6.5) 17.0   
18a   1.24 s 28.5 
19   1.11 s 17.0 
20   1.83 s 12.3 
Glc 1' 1.87 s 15.6   
2' 1.77 s 22.3   
3' 4.52 d (7.5) 104.8   
4' 3.20 dd (9.5, 7.5) 75.0   
5' 3.38 t (9.5) 78.0   
6'a 3.36 t (9.5) 71.0   
6'b 3.40 m 78.0   
7-CH3CO    2.00 s 20.7 
CH3CO    171.3 
8-CH3CO   2.12 s 21.7 
CH3CO    171.6 
15-CH3CO   2.12 s 21.7 
CH3CO    171.6 
Isobut 1    177.3 
2   2.35 sept (7.0) 35.6 
3/4   1.26 d (6.5) 19.5 
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Table 5.3. 
1
H and 
13
C NMR Data of Compound 4 and 9 (Methanol-d4, 600 MHz) 
 
                     4                         9  
position H C H C
1a 2.23 br d (14.0) 49.6  43.6 
1b 1.08 dd (14.0, 4.5)    
2a 3.84 br dd (4.5, 3.5) 66.8 2.96 d (13.5) 53.0 
2b   1.86 d (13.5)  
3a 1.79 dd (12.5, 5.0) 51.9  215.2 
3b 1.21 dd (12.5, 3.5)    
4a  35.0 2.80 t (13.5)  41.5 
4b   2.29 dq (13.5, 6.7, 4.0, 2.0)  
5 1.26 dd (12.0, 3.0) 56.0 2.21 m 43.6 
6a 1.86 m 27.0  78.1 
6b 1.57 m    
7a 2.58 br d (13.0) 37.0 5.80 d (15.5) 132.0 
7b 2.29 m    
8  152.2 5.98 dd (15.5, 6.2) 137.6 
9 2.39 d (8.5) 53.0 4.37 q (12.6, 11.5, 6.0, 4.7) 69.0 
10  42.0 1.29 d (6.0) 24.4 
11a 2.63 dd (13.0, 7.0) 28.8 0.92 s 24.0 
11b 1.52 m    
12 4.99
b
 77.2 0.92 s 24.0 
13a  157.7 3.85 dd (11.0, 5.0) 64.0 
13b   3.61 dd (11.0, 2.5)  
14 6.49 s 113.4   
15  116.8   
16  176.0   
17 0.94 s 23.3   
18 1.00 s 34.0   
19 1.03 s 34.7   
20 1.70 s 8.9   
a 
J values are in parentheses and reported in Hz; chemical shifts are given in ppm;  
assignments were confirmed by DQF-COSY, 1D-TOCSY, HSQC, and HMBC experiments.  
b
 overlapped signal.
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Table 5.4. Proteins identified in PC3 and MCF7 cell lines by DARTS method 
PC3 MCF7 
Heat shock cognate 71kDa protein ADP/ATP translocase 2 
ATP synthase subunit alpha Clathrin heavy chain 1 
Dihydrolipoyl dehydrogenase 3-hydroxyacyl-CoA dehydratase 3 
Protein disulfide-isomerase A4  
Clathrin heavy chain 1  
ATP synthase subunit   
Threonine-tRNA ligase  
Very long-chain specific acyl-CoA dehydrogenase  
Myoferlin  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
CHAPTER 6 
                Phytochemical study of Bidens humilis 
Kunth syn. Bidens triplinervia Kunth. 
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Chapter 6  
 
6.1 Introduction: Bidens genus 
 
The genus Bidens L., Asteraceae family, comprises about 240 species of annual or 
perennial herbs, widely distributed in tropical and subtropical countries, especially in 
America. The chemical study of many of these species has been carried out in order to 
obtain chemotaxonomic information to contribute to the classification of the Asteraceae, on 
the basis of the different compounds found, as acetylenes, sesquiterpenes lactones and 
flavonoids (Silva et al., 2011). Plants of the genus are used in many indigenous systems of 
medicines as anti-inflammatory, antiallergic, antibacterial, antidiabetic, antimalarial, 
antiviral, antihypertensive, and antioxidant remedies (Bairwa et al., 2010). Bidens species 
are mainly rich in addition of the compounds mentioned before in phenol glycosides (De 
Tommasi et al., 1998; Wang et al., 2003). 
Bidens humilis Kunth syn. Bidens triplinervia Kunth (Figure 6.1) is a plant used in 
Ecuadorian folk medicine for the treatment of headache, fever and liver diseases, while the 
flower infusion against gastric and abdominal pain. Moreover, the indigenous Salasacas 
used the yellow flowers to dye wool and other clothes. Nevertheless, no phytochemical 
study on this species was reported in the literature. For this species, an antioxidant-oriented 
approach was carried out on the aerial part plant extracts. 
 
Figure 6.1: Bidens humilis 
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6.2 Plant material 
 
Aerial parts of Bidens humilis Kunth were collected in Tumbaco, Ecuador, on September 
2011. The plant was identified at the Herbarium of Jardin Botanico de Quito, Quito, 
Ecuador. A voucher specimen (N. 9237 Bidens humilis/1) was deposited at Herbarium 
Horti Botanici Pisani, Nuove Acquisizioni, Pisa, Italy. 
 
6.3 Extraction and isolation 
 
The dried aerial parts of B. humilis (610 g) were extracted for 48 h with solvents of 
increasing polarity, n-hexane, CHCl3 and MeOH by exhaustive maceration (2 L), to give 
5.7, 16.0, 26.8 g of the respective residues. The MeOH extract was partitioned between n-
BuOH and H2O, to afford a n-BuOH residue (4.0 g). Part of the n-BuOH extract (2.5 g) was 
submitted to a Sephadex LH-20 column (3 x 100 cm, flow rate 1.0 mL/min) using MeOH 
as eluent and collecting 56 fractions of 10 mL that were grouped by TLC into six major 
fractions (A-F). Fractions B (230 mg, 230-290 mL), C (122 mg, 300-330 mL), and E (93.6 
mg, 390-480 mL) were subjected to RP-HPLC with MeOH–H2O (3:7) as eluent to give 
pure compounds 5 (2.4 mg, tR =33 min), 10 (3.6 mg, tR = 46 min), and 6 (3.7 mg, tR = 100 
min) from fraction B; compounds 3 (5.1 mg, tR = 23 min), 1 (5.3 mg, tR = 32 min), and 9 
(2.0 mg, tR = 53 min) from fraction C; compound 11 (2.2 mg, tR = 16 min) from fraction E, 
respectively. Fraction D (185 mg, 340-380 mL) was purified by RP-HPLC with MeOH–
H2O (2:3) as eluent to give pure compounds 2 (1.6 mg, tR = 32 min), 4 (2.5 mg, tR = 40 
min), and 8 (4.0 mg, tR = 90 min). Fraction F (490-560 mL) yielded pure compound 7 (14.5 
mg).  
The structures of compounds 1-11 are showed in Figures 6.2 
 
6.4 New isolated compounds 
 
(2S)-Isookanin 7-O--L-arabinopyranoside (1)  
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Yellow amorphous powder;  25D -22 (c 0.3, MeOH); UV (MeOH) max (log ): 281 (4.31), 
327 (3.87); CD []25 (c 0.05, MeOH, nm) – 5020 (274 nm), + 4380 (306 nm); 
1
H and 
13
C 
NMR data, see Table 6.1; ESI MS m/z 419 [M-H]-, 287 [(M- 132)-H]-; HR ESIMS [M-H]- 
419.0984 (calcd for C20H19O10 419.0978), 287.0602 [(M-132)-H]
-
, 151.0058 [C7H4O4-H]
-
, 
135.0049 [C7H4O3-H]
-
. 
 
(2S)-Isookanin 7-O-(2''-acetyl)--L-arabinopyranoside (2)  
Yellow amorphous powder;  25D  -29 (c 0.06, MeOH); UV (MeOH) max (log ): 283 
(4.12), 330 (3.98); CD []25 (c 0.05, MeOH, nm) – 6400 (275 nm), + 4560 (307 nm); 
1
H 
and 
13
C NMR data, see Table 6.1; ESI MS m/z 461 [M-H]
-
; HR ESIMS m/z 461.1090 [M-
H]
-
 (calcd for C22H22O11 461.1084), 401.1067 [(M-60)-H]
-
, 287.0865 [(M-174)-H]
-
, 
151.0043 [C7H4O4-H]
-
 and 135.0041 [C7H4O3-H]
-
. 
 
Luteolin 7-O--D-glucopyranosyl-(16)--D-galactopyranoside (6) 
Yellow amorphous powder;  25D  -45 (c 0.2, MeOH); UV (MeOH) max (log ): 270 (4.33), 
335 (3.96); 1H and 13C NMR data, see Table 6.1; ESI MS m/z 609 [M-H]-, 447 [(M-162)-
H]
-
, 285 [(M-162-162)-H]
-
, 633 [M+Na]
+
; HR ESIMS m/z 609.1461 [M-H]
-
 (calcd for 
C27H29O16 609.1458). 
 
6.5 Structural elucidation and biological activity, antioxidant activity of extracts, 
fractions and pure compounds 
 
The aerial parts of B. humilis were sequentially extracted with solvent of increasing polarity 
giving n-hexane, chloroform, and methanol residues. The methanol extract was partitioned 
between n-BuOH and water, yielding a n-BuOH fraction. All extracts were subjected to the 
2,2-Diphenyl-2-picrylhydrazyl (DPPH), β-carotene bleaching (BCB) and ferric reducing 
antioxidant power (FRAP) assays to screen their antioxidant activity. Total Phenolic 
Content (TPC) was also measured. A single assay cannot determine completely the 
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antioxidant activity of a phytocomplex, thus different approaches are needed to study its 
biological potential (Girones-Vilaplana et al., 2012). For this reason the antioxidant activity 
was tested by using three complementary systems. A new concept, Relative Antioxidant 
Capacity data Index (RACI) was applied integrating antioxidant capacity data determined 
by the different methods. TPC results were included in RACI calculation since phenolics 
can act with other mechanisms (not measurable with our tests) and can contribute 
significantly to phytocomplex health promoting value. Moreover it was recently proposed 
that results obtained by Folin-Ciocalteu procedure could also be interpretedas an alternative 
way to measure the total reducing capacity of extracts  as the reagent reacts with any 
reducing substance (Fernandes et al., 2013) In this way RACI provided a more 
comprehensive assessment of the whole antioxidant potential. The n-BuOH fraction 
demonstrated to be the one containing the highest concentration of total phenolics (from 8 
to 20 times higher than the other extracts) (Table 6.1). The high phenolic content of a 
phytocomplex is usually directly related to its antioxidant activity measured with DPPH 
and FRAP tests, while there are evidences that it is not the same with BCB test (Milella et 
al., 2014). This phenomenon can be explained by the affinity of the antioxidant complex 
for the lipids and thus the lipophilic nature of BCB test could be the determining factor 
(Milella et al., 2014; Von Gadow et al., 1997). Our results confirmed this evidence since 
the n-BuOH extract was more active as radical scavenger (DPPH) and as antioxidant 
(FRAP) than as antilipoperoxidative (BCB). RACI was calculated to examine obtained 
results and the n-BuOH extract was confirmed to be the most active (Figure 6.3a). The n-
BuOH extract was subjected to Sephadex LH-20 column chromatography collecting six 
major fractions. Also in this case all fractions were evaluated for their TPC and antioxidant 
activities (Table 6.1). All fractions are rich in phenolics with a total content higher than 
361.8 mg of gallic acid equivalents per g of extract (mgGAE/g) (fraction C) to 518.0 
mgGAE/g for fraction F, with the exception of fraction A (90.1 mgGAE/g). Fraction E 
showed the highest DPPH and FRAP values [857.3 and 2208.8 mg of Trolox equivalent per 
g (mgTE/g) of extract respectively], while content. Fraction F showed the presence of one 
spot on TLC and was directly subjected to spectroscopic and spectrometric analyses. 
Fractions B-E were purified by RP-HPLC; totally eleven compounds the highest BCB 
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value was registred for fraction F. On the basis of RACI results (Figure 6.3a) and on the 
evidence that the most promising fractions should have at least one value higher than their 
relative extract, fraction A was excluded from further analysis. All selected fractions were 
investigated for their phytochemical (1-11) were characterized (Figure 6.2) of which three 
were new natural flavonoids (1, 2, and 6). Fraction E showed the highest DPPH and FRAP 
values [857.3 and 2208.8 mg of Trolox equivalent per g (mgTE/g) of extract respectively], 
while the highest BCB value was registred for fraction F. On the basis of RACI results 
(Figure. 2a) and on the evidence that the most promising fractions should have at least one 
value higher than their relative extract, fraction A was excluded from further analysis. All 
selected fractions were investigated for their phytochemical content. Fraction F showed the 
presence of one spot on TLC and was directly subjected to spectroscopic and spectrometric 
analyses. Fractions B-E were purified by RP-HPLC; totally eleven compounds (1-11) were 
characterized (Figure. 1) of which three were new natural flavonoids (1, 2, and 6). 
A molecular formula of C20H20O10 was assigned to compound 1 on the basis of its HR 
ESIMS (m/z 419.0984 [M-H]-) and 13C NMR data. The ESI MS spectrum of 1 showed a 
quasimolecular ion peak at m/z 419 [M-H]- and one peak at m/z 287 [(M-132)-H]-, due to 
the loss of one pentose moiety. Moreover, HR ESIMS/MS analysis revealed fragment ions 
at m/z 151.0058 [C7H4O4-H]
-
 and 135.0049 [C7H4O3-H]
-
, diagnostic for flavanoids carrying 
two hydroxyl groups on the A ring (de Rijke et al., 2006). The UV absorption bands at 281 
and 327 nm were suggestive of a flavanone skeleton. The 1H and 13C NMR spectra (Table 
6.2) displayed signals for an oxygenated methine doublet of doublets at   5.46 (1H, dd, J = 
12.5, 3.0 Hz, H-2), two methylene doublet of doublets at  3.14 (1H, dd, J = 17.0, 12.5 Hz, 
H-3ax) and 2.82 (1H, dd, J = 17.0, 3.0 Hz, H-3eq) and five aromatic protons of which two 
superimposable, that were assigned with the help of 1D TOCSY and DQF COSY, together 
with signals of a sugar residue. The chemical shifts of the two doublets at  7.40 (1H, d, J = 
8.0 Hz, H-5) and 6.89 (1H, d, J = 8.0 Hz, H-6) suggested a 7,8-disubstituted A-ring, while 
the three signals at  7.01 (1H, d, J = 2.0 Hz, H-2'), 6.89 (1H, dd, J = 8.5, 2.0 Hz, H-6'), and 
6.81 (1H, d, J = 8.5 Hz, H-5') were in accordance with a 1,2,4-trisubstituted B-ring. The 
twenty 13C NMR resonances (Table 6.2) were easily assigned to a flavanone aglycone 
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moiety and to an -arabinose unit (C 102.7, 73.1, 71.4, 68.9, and 66.6). These 1D NMR 
data, in combination with the observed 2D NMR correlations, suggested that compound 1 
was a flavanone having isookanin as aglycone (Agrawal, 1989). The position of the 
arabinose residue was deduced by the HMBC correlation between  4.97 (H-1ara) and 151.8 
ppm (C-7). Hydrolysis of 1 with 1N HCl, followed by GC analysis through a chiral column 
of the trimethylsilylated sugar, led to the assignment of arabinose configuration. The 
stereochemistry of C-2 was determined as S on the basis of a negative Cotton effect at 274 
nm and a positive Cotton effect at 306 nm in the CD spectrum of 1. Consequently, 1 was 
characterized as (2S)-isookanin 7-O--L-arabinopyranoside. 
The molecular formula of compound 2 (C22H22O11) was established by 
13
C NMR and HR 
ESIMS spectra (m/z 461.1090 for [M-H]
-
). In the HR ESIMS/MS spectrum fragments at 
m/z 401.1067 [(M-60)-H]
-
, 287.0865 [(M-174)-H]
-
, 151.0043 [C7H4O4-H]
-
 and 135.0041 
[C7H4O3-H]
-
 were also observed. Its NMR spectral data (Table 6.2) suggested that the 
structure of 2 resembled that of 1, but differed for the presence of an additional acetyl 
group. The 
13
C NMR data (Table 6.2) were consistent with the presence of another 
isookanin glycoside, suggesting that the acetyl moiety should be linked to the arabinose 
residue. The acylation site was on C-2 of arabinose as evidenced by the strong deshielding 
of H-2ara at  5.30 and was confirmed by HMBC experiment (Sun et al., 2007). The 
stereochemistry at C-2 and the sugar unit configuration were determined as reported for 1. 
Thus, the structure of 2 was deduced to be (2S)-isookanin 7-O-(2''-acetyl)--L-
arabinopyranoside.  
Compound 6 (C27H30O16) showed a quasimolecular ion peak at m/z 609.1461 [M-H]
-
 in the 
negative HR ESIMS. The prominent fragment ions observed in the ESI MS spectrum at m/z 
447 [(M-162)-H]
-
 and 285 [(M-162-162)-H]
-
 together with the UV absorption maxima at 
270 and 335 nm suggested the presence of a flavone glycoside. Analysis of the 1H and 13C 
NMR spectra (Table 6.2) of 6 clearly indicated that it was a luteolin derivative. The 
13
C 
NMR spectrum allowed to assign 15 signals to the aglycone moiety and 12 to the sugar 
residue, consisting of one inner -galactose and one terminal -glucose. The linkage 
between sugar moieties was deduced by HMBC correlation between the signal at  4.39 
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(1H, d, J = 7.8 Hz, H-1glc) and 69.3 (C-6gal). Hydrolysis of 6 with 1N HCl, followed by GC 
analysis through a chiral column of the trimethylsilylated monosaccharides, permit the 
assignment of sugars configuration. Accordingly, compound 6 was assigned as luteolin 7-
O--D-glucopyranosyl-(16)--D-galactopyranoside. 
Compounds 3-4 and 7-11 were characterized as isookanin 7-O--D-glucopyranoside or 
flavanomarein (3) (Shimokoriyama, 1957), 8-methoxybutin (4) (Okada et al., 2014), butin 
7-O--D-glucopyranoside or isocoreopsin (5) (Gupta et al., 1970), luteolin (7) (Agrawal, 
1989), chrysoeriol 7-O-β-D-glucopyranoside or thermopsoside (8) (Romussi et al., 1996), 
eriodictyol 7-O-β-D-glucopyranoside (9) (Agrawal, 1989), 6',6''-sucrose ester of 
(1,2,3,4)-3,4-bis-(4-hydroxyphenyl)-1,2-cyclobutanedicarboxilic acid (10) (Wang et 
al., 2003), and chlorogenic acid (11) (Iwai et al., 2004) by spectrometric and spectroscopic 
data measurement and comparison with the literature data. 
Finally, the biological activity of these new and known compounds using BCB, FRAP, and 
DPPH tests was measured (Table 6.1). Among known compounds luteolin (7) showed the 
highest values: 819.5 mgTE/g, 40.6% of antioxidant activity (AA), 1442.3 mgTE/g in 
DPPH, BCB and FRAP tests, respectively. These findings are congruent with previous 
evidences (Choi et al., 2014; Zhang et al., 2014). On the other hand, among new natural 
compounds, 1 showed to be the most active in DPPH and FRAP tests. On the basis of 
RACI (Figure 6.3b), that reflects the results obtained from all antioxidant tests, it is 
possible to assess that 7 and 1 are the most active compounds followed by compound 11 
and a group formed by compounds 9, 4, 3, 6, and 2. This group showed close but slightly 
descending RACI values. The lowest RACIs were observed for compounds 5, 8 and 10. All 
isolated compounds are flavonoid derivatives with the exclusion of 10 and 11, and on the 
basis of their structures it is possible to confirm the importance of the adjacency of the two 
hydroxyl groups in the ortho-diphenolic arrangement (compounds 7, 1, 11, 9, 4, 3, 6, 2). 
The loss of activity of compound 8 could be ascribed to the presence of a methoxy group 
on the B-ring. This result is congruent with previous findings where it was demonstrated 
that the presence of a methoxy group decreases sensibly the antioxidant capacity of 
flavonoids (Heim et al., 2002; Rice-Evans et al., 1996). Some of the pure compounds tested 
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exerted interesting antioxidant activity, and their action could partially explain the activity 
shown by the fraction they come from. Thus, in order to deepen the polar fraction 
metabolome of B. humilis, the n-BuOH extract was subjected to LC-HRESIMS and LC-
HRESIMS/MS analyses both in positive and in negative ion mode (Figure 6.4). Twenty-
four major compounds were detected including the eleven isolated compounds; on the basis 
of accurate molecular weight determination, and taking into account the main fragments 
observed, the structure of further thirteen derivatives was proposed (Table 6.3). The 
presence of these additional phenolic compounds could explain the antioxidant activity of 
B. humilis n-BuOH extract. 
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Figure 6.2: Chemical structures of compounds 1-11 
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Figure 6.3: Relative Antioxidant Capacity Index (RACI) values of extracts (BH-C: 
chloroform; BH-E: n-hexane; BH-B: n-BuOH), Sephadex-LH20 fractions (indicated with 
letters) (a), and pure compounds (indicated with numbers) (b) obtained from Bidens humilis 
aerial parts. 
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Figure 6.4: Total ion current LC-HRESIMS chromatograms obtained for the n-BuOH 
fraction of the aerial parts of B. humilis in negative (A) and in positive (B) ion mode. 
 
 
 
 
 
 
 
 
 
A 
B 
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Table 6.1. Antioxidant activity and total phenolic content of B. humilis extracts and 
fractions using DPPH, BCB, FRAP, and Folin assays. 
 
Sample TEST 
Extract DPPH  
mgTE/g* 
BCB 
%AA** 
FRAP  
mgTE/g* 
Folin 
mgGAE/g*** 
n-hexane 34.9±1.7 43.6±2.9 6.5±0.5 34.0±2.2 
CHCl3 37.6±2.4 37.9±1.9 31.3±2.1 13.3±0.9 
n-BuOH 173.8±6.2 8.0±0.7 790.1±12.5 261.7±11.0 
Fraction     
A 27.4±1.0 13.8±0.4 115.0±9.2 90.1±5.2 
C 163.8±8.5 9.4±0.2 620.7±19.5 361.8±22.2 
B 147.1±11.2 3.2±0.4 675.1±23.1 451.0±21.3 
D 296.3±14.5 4.5±0.5 954.3±12.7 495.5±24.2 
E 857.3±18.8 11.4±0.7 2208.8±45.2 511.1±19.7 
F 819.5±21.2 40.6±1.1 1442.3±32.1 518.0±16.5 
Pure compound     
8 151.5±3.2 9.5±0.7 170.5±4.5  
10 317.5±12.2 14.4±0.9 297.5±7.4  
5 238.0±7.7 23.2±1.1 421.2±9.2  
2 484.7±21.3 10.3±0.8 777.6±12.4  
6 357.8±17.5 17.1±1.0 823.8±11.4  
3 356.5±16.4 20.5±1.5 707.4±12.6  
4 255.3±12.9 22.3±1.1 1129.7±24.0  
9 477.1±14.5 21.0±0.9 770.8±7.0  
11 470.7±21.6 19.3±1.7 953.1±12.9  
1 513.7±28.7 16.8±1.0 1404.2±15.6  
7 819.5±22.5 40.6±2.1 1442.3±17.8  
Values are the mean of three determinations (P < 0.05). *Milligrams of Trolox Equivalents  
per g of Extract/Fraction/Pure compound; **Antioxidant activity at [0.05 mg/mL];  
*** Milligrams of Gallic Acid Equivalents per g of Extract/Fraction/Pure compound. 
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Table 6.2. 
1
H and 
13
C-NMR data of compounds 1, 2, and 6 (CD3OD, 600 MHz, J in Hz) 
 
position 1  2               6  
 H C H C H C 
2 5.46 dd (12.5, 3.0) 81.0 5.43 dd (12.8, 3.0) 81.4  166.0 
3ax 3.14 dd (17.0, 12.5) 45.0 3.14 dd (17.2, 12.8) 44.6 6.62 s 103.1 
3eq 2.82 dd (17.0, 3.0)  2.77 dd (17.2, 3.0)    
4  193.0  193.3  182.9 
5 7.40 d (8.0) 118.0 7.38 d (8.2) 118.0  161.4 
6 6.89 d (8.0) 110.0 6.88 d (8.2) 111.3 6.62 d (2.0) 101.7 
7  151.8  150.6  163.0 
8  135.6  136.3 6.83 d (2.0) 95.2 
9  155.0  155.4  157.8 
10  113.9  113.0  105.9 
1'  130.6  130.5  122.3 
2' 7.01 d (2.0) 114.5 7.02 d (2.0) 114.9 7.45 d (2.0) 113.2 
3'  145.0  145.0  145.9 
4'  145.9  145.8  150.0 
5' 6.81 d (8.5) 115.7 6.81 d (8.5) 115.9 6.94 d (8.0) 115.6 
6' 6.89 dd (8.5, 2.0) 118.9 6.88 dd (8.5, 2.0) 119.2 7.45 dd (8.0, 2.0) 119.5 
Ara 1 4.97 d (7.0) 102.7 5.17 d (6.8) 100.6   
2 3.92 dd (9.0, 7.0) 71.4 5.30 dd (9.0, 6.8) 73.0   
3 3.70 dd (9.0, 2.5) 73.1 3.88 dd (9.0, 2.5) 71.6   
4 3.94 m 68.9 3.94 m 68.6   
5a 3.95 dd (12.0, 2.0) 66.6 3.98 dd (12.0, 2.0) 66.7   
5b 3.74 dd (12.0, 3.5)  3.72 dd (12.0, 3.5)    
COCH3    171.3   
COCH3   2.12 s 21.0   
Gal 1     5.09 d (7.5) 100.5 
2 -    3.52 dd (9.0, 7.5) 73.9 
3     3.53 dd (9.0, 4.0) 76.3 
4     3.47 dd (4.0, 2.5) 70.3 
5     3.83 m 76.6 
6a     4.23 dd (12.0, 2.5) 69.3 
6b     3.87 dd (12.0, 4.5)  
Glc1     4.39 d (7.8) 103.9 
2     3.30 dd (9.0, 7.8) 74.0 
3     3.29 t (9.0) 77.4 
4     3.45 t (9.0) 70.6 
5     3.37 m 77.0 
6a     3.91 dd (12.0, 3.0) 62.0 
6b     3.69 dd (12.0, 5.0)  
Data assignments were confirmed by DQF-COSY, 1D-TOCSY, HSQC, and HMBC experiments 
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Table 6.3. Identification of the major compounds observed in the HR-LCMS analysis of B. 
humilis extract both in negative or positive ion mode (Figure 6.3). 
R.t. 
(min) 
Experimental 
MW 
Positive 
ion mode 
(m/z) 
Negative 
ion mode 
(m/z) 
Main fragments 
(m/z) 
Attempted 
id./compound 
Theoretica
l MW 
0.4 312.1053 
 
311.0874 
179.07, 139.06, 
135.06, 131.05, 
89.01  
 
312.0845 
0.5 354.1002 
 
353.0923 
191.04, 179.04, 
135.03 
11 354.0951 
7.8 516.1309 
 
515.123 
353.09, 191.07, 
179.06, 135.03 
Dicaffeoylquinic acid 516.1268 
8 610.1576 
 
609.1497 
447.11, 301.09, 
151.01 
 
610.1534 
9.8 
 
450.1186 
 
449.1107 
287.09, 151.01, 
135.01 
3
1
 450.1162 
288.0719 289.0696 287.0743 
179.01, 151.01, 
135.01 
 
288.0634 
10.7 
 
464.1200 465.1005 463.1395 
301.07, 179.01, 
151.01, 135.01 
 
464.0955 
13 434.0940 
 
433.0862 
303.05, 151.01, 
135.01 
 
434.0849 
13.1 610.1595 611.1603 609.1587 
447.11, 285.10, 
151.01, 135.00 
6 610.1534 
13.9 450.1168 
 
449.1089 
287.08, 151.01, 
135.01 
9
1
 450.1162 
14.9 420.1087 
 
419.1008 
287.09, 151.01, 
135.01 
1 420,1056 
16 288.0718 289.0696 287.0741 
179.01, 151.01, 
135.01 
 
288.0624 
17.2 462.1183 463.1129 461.1237 
446.13, 299.04, 
285.04, 151.05 
8 462.1162 
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300.0695 301.0743 299.0648 
284.06, 165.01, 
151.09, 135.01 
 
300.0634 
17.8 434.1245 
 
433.1166 271.05, 125.01 5 434.1213 
18.8 
462.1170 463.1167 461.1174 
401.10, 287.09, 
151.01, 135.01 
2 462.1162 
634.1905 
 
633.1826 
487.18, 353.17, 
293.09, 163.01, 
145.01 
10 634.1898 
286.0569 287.0403 285.0736 151.01, 135.01 7 286.0477 
20.6 
302.0852 303.0833 301.0871 286.08, 165.01 4 302.0790 
530.1568 
 
529.1489 
367.13, 301.10, 
287.09, 179.07, 
161.05, 131.01, 
135.01 
  
22.1 676.2078 
 
675.1999 
463.16, 403.12, 
211.11, 87.01   
27.4 824.3918 
413.2037 
[M+2H]
2+
 
 
678.36, 621.28, 
474.25, 276.18, 
148.00 
Peptide (FGAVVFGE) 824.4069 
30.7 448.0892 449.0842 447.0943 
285.09, 151.01, 
135.01 
Glycosil-luteolin 448.1006 
31.7 
554.0938 
 
553.0859 419.04, 413.03 Dimeric-luteolin 554.0849 
326.2112 
 
325.2033 
255.10, 183.06, 
97.00   
34.0 340.2192 
 
339.2113 
269.10, 183.07, 
97.00   
35.6 
286.0577 
 
285.0498 151.01, 135.01 Luteolin 286.0477 
254.0631 
 
253.0552 151.01, 135.01 Chrysin 254.0579 
36.9 370.0548 371.0627 
 
259.06, 127.01 
  
37.8 426.1431 427.151 
 
259.07, 127.03 
  1
 This identification was confirmed by pure compound injection  
pen = pentose 
hex = hexose 
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igniaria Humb. & Bonpl 
 
Phytochemical studies Chapter 7 
 
- 62 - 
 
Chapter 7 
 
7.1 Introduction: Andromachia genus 
 
In 1809 Bonpland described, in his publication “Plantes Equinoxiales”, twelve new species 
from Ecuador. Within this group maybe the most interesting species correspond to 
Andromachia igniaria Humb. & Bonpl.(Figure 7.1). Andromachia is a genus of flowering 
plants in the Asteraceae family, which was recognized in 1819 as a synonym of Liabum and 
placed in the Vernonieae (Brettell et al., 1973). This species was found for the first time 
near Quito - Ecuador, in a zone called Valle de los Chillos. The name “igniaria”, that 
means “of fire”, comes from the intense yellow color of the inflorescences. The species is 
widely distributed in the Andes mainly from Colombia and Ecuador, between 2000 and 
3500 m a.s.l., and has also the synonym Liabum igniarum Less. It is a shrub, 1-3 m high, 
with bracts separated by petioles, opposite petiolated leaves, with abundant white pubescent 
in the underside, top inflorescence, ligulate yellow flower and the fruit is an achene. The 
plant is very used by peasants that take advantage of the bark to make fire to cook or to 
warm up homes.  Leaves are also used to feed guinea pigs, as well as to prepare an special 
sweet bread called “pan de leche”.  In popular medicine people use the leaves to wash the 
body for purification, to treat headache or to heal wounds.  
Few informations are reported about previous investigations carried out on some species of 
Andromachia genus, from Central and South America, that result basically on the isolation 
of some simple sesquiterpene lactones, triterpenes, and flavonoids (Bohlmann et al., 1984; 
Jakupovic et al., 1988; Juarez et al., 1995).          
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Figure 7.1: Andromachia igniaria  
 
7.2 Plant material 
 
Aerial parts of A. igniaria were collected in Tumbaco, Ecuador in September 2011. The 
plant was identiﬁed at the Herbarium of Jardin Botanico de Quito, Quito, Ecuador. A 
voucher specimen (N. 9371 Andromachia igniaria /1) was deposited at Herbarium Horti 
Botanici Pisani, Pisa, Italy. 
 
7.3 Extraction and isolation 
 
The dried and powdered aerial parts (580 g) of A. igniaria were in sequence extracted for 
48 h with n-hexane, CHCl3, CHCl3-MeOH (9:1) and MeOH, by exhaustive maceration (3 x 
2 L), to give 8.2, 14.9, 6.3 and 23.1 g of the respective residues.  
The MeOH extract was partitioned between n-BuOH and H2O to afford a n-BuOH residue. 
The n-BuOH fraction (4 g) was submitted to Sephadex LH-20 column  (3 x 100 cm, flow 
rate 1.0 mL/min) using MeOH as eluent to obtain sixteen major fractions (A-P) grouped by 
TLC. Fraction G (109.2 mg) was subjected to RP-HPLC with MeOH-H2O (45:55) as eluent 
yielding a new flavonoid 3',4',7,8-tetrahydroxyflavanone 7-O-(6''-O-acetyl)--D-
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glucopyranoside (compound 1, 4.3 mg, tR = 10 min ), and caffeic acid metil ester 
(compound 2,  1.9 mg, tR = 14 min), rutin (compound 3,  2.7 mg, tR = 15 min) and 
kaempferol 3-O -β-D-glucopyranoside (compound 4,  0.9 mg, tR = 21 min) . Fractions A 
(215.2 mg), B (136.8 mg), N (20.3 mg) and P (25 mg) were separately purified by RP-
HPLC with MeOH-H2O (1:1) as eluent to give 3-β-D-glucopyranosyloxy-1-hydroxy-6(E)-
tetradecene 8,10,12-triyne  (compound 5,  2.2 mg, tR = 35 min), eugenyl O-β-D-
glucopyranoside (compound 6,  1.5 mg, tR = 10 min) from fraction A,  2-β-D-
glucopyranosyloxy-1-hydroxytrideca-5,7,9,11-tetrayne (compound 7,  0.8 mg, tR = 38 min) 
from B, eriodictyol (compound 8,  1.9 mg, tR = 12 min) from N, finally okanin (compound 
9,  1.4 mg, tR = 13 min), butein (compound 10,  17.3 mg, tR = 22 min) and luteolin 
(compound 11,  0.3 mg, tR = 25 min) from fraction P. Fractions E (70.9 mg), I (143.3 mg), J 
(424.9 mg) and L (67.9 mg) were also subjected to to RP-HPLC with MeOH-H2O (45:55) 
as eluent to obtain bidenoside F (compound 12,  1.3 mg, tR = 13 min) from E, compound 4 
(1.8 mg, tR = 20 min), quercetin 3-O-β-D-glucopyranoside (compound 13,  5.3 mg, tR = 15 
min) from J, okanin 4’-O-β-D-glucopyranoside (compound 14,  14.2 mg, tR = 12 min) and 
luteolin 4’-O-β-D-glucopyranoside (compound 15,  1.1 mg, tR = 23 min) from fraction L.  
The CHCl3-MeOH extract (6 g) was subjected to Sephadex LH-20 column (3 x 100 cm, 
flow rate 1 mL/min) eluting with MeOH to give eleven major fractions (A-K) grouped by 
TLC, together with pure luteolin  (compound 11, 11.6 mg). Fraction E (232 mg) was 
purified by RP-HPLC with MeOH-H2O (55:45) as eluent to afford compound 5 (1 mg, tR = 
19 min). Fraction G (130.7 mg) was purified by RP-HPLC with MeOH-H2O (4:6) as eluent 
yielding compound 1 (1 mg, tR = 16 min). Fraction H (108 mg) was subjected to RP-HPLC 
with MeOH-H2O (45:55) as eluent to give compound 1 (1.1 mg, tR = 10 min) and caffeic 
acid (compound 16, 5.3 mg, tR = 6 min). Finally fraction I (34.1 mg) was purified by RP-
HPLC with MeOH-H2O (1:1) as eluent to afford a new flavonoid 3',4',7,8-
tetrahydroxyflavone 7-O-(6''-O-acetyl)--D-glucopyranoside (compound 17, 2 mg, tR = 18 
min). 
The structures of new compounds are shown in Figure 7.2. The structures of the other 
knowm compounds are reported in Figures 7.3-7.5. 
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7.4 New isolated compounds 
 
3',4',7,8-tetrahydroxyflavanone 7-O-(6''-O-acetyl)-β-D-glucopyranoside (1)   
Yellow amorphous powder;  25D -40 (c 0.4, MeOH); UV (MeOH) max (log ): 328 (4.19), 
284 (3.90); CD []25 (c 0.05, MeOH, nm) – 5000 (276 nm), + 4520 (304 nm); 
1
H and 
13
C 
NMR data, see Table 7.1; ESI MS m/z 491 [M-H]
-
, 473 [M-H-18]
-
, 287 [M-H-204]
-
, HR 
ESIMS [M-H]
-
 491.1182 (calcd for C23H23O12 491.1190), 355.1042 [M-H-134]
-
, 287.0993 
[M-H-204]
-
. 
 
3',4',7,8-tetrahydroxyflavone 7-O-(6''-O-acetyl)-β-D-glucopyranoside (17) 
Yellow amorphous powder;  25D  -35 (c 0.078, MeOH); UV (MeOH) max (log ): 258 
(4.07), 321 (3.85); 1H and 13C NMR data, see Table 7.1; ESI MS m/z 489 [M-H]-; HR 
ESIMS m/z 489.1041 [M-H]
-
 (calcd for C23H21O12 489.1033), 355.0972 [M-H-134]
-
, 
285.0944 [M-H-204]
-
. 
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Figure 7.2: Structures of compounds 1 and 17 
 
7.5 Structural elucidation 
 
Compound 1 was obtained as a yellow powder, analyzed for the molecular formula 
C23H24O12 by HRESI-MS at m/z 491.482 [M−H]
-
 (calcd for C23H23O12, 491.1190), which 
was further confirmed by 
13
C NMR and DEPT spectra. The ESI MS spectrum of compound 
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1 showed a quasimolecular ion peak at m/z 491 [M-H]
-
 and one peak at m/z 287 [M-H-204]
-
, due to the loss of one acetylated hexose moiety. The UV absorption bands at 328 and 284 
nm were suggestive of a flavanone skeleton. In the 
1
H NMR spectrum, three aromatic 
protons signals (δ 7.04, d, J = 2.0 Hz; δ 6.92, dd, J = 8.5, 2.0 Hz; δ 6.82, d, J = 8.5 Hz) 
indicated an ABX system on ring B, and these proton signals were assigned to H-2', H-6' 
and H-5' by HSQC analysis. Likewise, another two aromatic protons signals (δ 7.40, d, J = 
8.0 Hz; δ 6.90, d, J = 8.0 Hz) were readily assigned to H-5 and H-6 of ring A. The 1H and 
13
C NMR spectra (Table 7.1) displayed also signals for an oxygenated methine doublet of 
doublets at  5.45 (1H, dd, J = 12.0, 3.0 Hz, H-2), two methylene doublet of doublets at  
3.16 (1H, dd, J = 17.0, 12.0 Hz, H-3ax) and 2.81 (1H, dd, J = 17.0, 3.0 Hz, H-3eq), that were 
assigned with the help of 1D TOCSY and DQF COSY, together with signals of a sugar 
residue and an acetyl group. These 1D NMR data, in combination with the observed 2D 
NMR correlations, suggested that compound 1 was a flavanone having isookanin as 
aglycone (Agrawal, 1989). The structure of the monosaccharide moiety of compound 1 was 
deduced using hydrolysis followed by trimethyl silylation and GC-analysis, 1D-TOCSY 
and DQF-COSY experiments. Thus, the chemical shifts of the sugar resonances were 
attributable to one -glucopyranosyl unit esterified at C-6 position. The substitution sites of 
the glucose and acetyl residues were also confirmed by the HMBC correlations between  
4.98 (H-1glc) and 152.2 ppm (C-7) and  4.45, 4.28 (H2-6glc) and 172.0 ppm (COCH3). The 
stereochemistry of C-2 was determined as S on the basis of a negative Cotton effect at 276 
nm and a positive Cotton effect at 304 nm in the CD spectrum. Thus, the structure of 
compound 1 was unambiguously elucidated as 3',4',7,8-tetrahydroxyflavanone 7-O-(6''-O-
acetyl)--D-glucopyranoside or 6''-O-acetyl-flavanomarein. 
The molecular formula of compound 17 (C23H22O12) was established by 
13
C NMR and HR 
ESIMS spectra (m/z 489.104 for [M-H]
-
). Its NMR spectral data suggested that the 
acetylated sugar moiety of compound 17 was superimposable to that of compound 1, while 
the aglycone was the point of difference. In fact, 1H and 13C NMR spectra (Table 7.1) 
revealed the presence of an additional aromatic signal (H 6.78 s, C 115.5), which could be 
easily assigned to ring C, and was consistent with the presence of 3',4',7,8-
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tetrahydroxyflavone as aglycone (Yang et al., 2012). The configuration of the sugar moiety 
was determined as reported for compound 1. Thus, the structure of 17 was elucidated as 
3',4',7,8-tetrahydroxyflavone 7-O-(6''-O-acetyl)--D-glucopyranoside. 
The following known compounds were identified by spectral analysis and comparison with 
published spectroscopic data: caffeic acid methyl ester (2), caffeic acid (16) (Saleem et al., 
2004), rutin (3) (Agrawal, 1989), kaempferol 3-O-β-D-glucopyranoside (4), 3-β-D-
glucopyranosyloxy-1-hydroxy-6(E)-tetradecene 8,10,12-triyne (5) (Rücker et al., 1992), 
eugenyl O-β-D-glucopyranoside (6) (Fujita et al., 1994), 2-β-D-glucopyranosyloxy-1-
hydroxytrideca-5,7,9,11-tetrayne (7) (Chiang et al., 2007), eriodictyol (8) (Agrawal, 1989), 
okanin (9), butein (10) (Chokchaisiri et al., 2009), luteolin (11), bidenoside F(12) (Li et al., 
2005), quercetin 3-O-β-D-glucopyranoside (13) (Agrawal, 1989), okanin 4’-O-β-D-
glucopyranoside (14) (Hoffmann and Bhölzl, 1988) and luteolin 4’-O-β-D-glucopyranoside 
(15) (Nawwar et al.,1994).
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Figure 7.3: Structures of known 
compounds from A. igniaria 
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 Figure 7.5: Known compounds isolated from A. igniaria 
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Table 7.1. 
 1
H and 
13
C-NMR data of compounds 1 and 17 (CD3OD, 600 MHz, J in Hz) 
 
position       1  17  
 H C H C 
2 5.45 dd (12.0, 3.0) 81.5  154.0 
3ax 3.16 dd (17.0, 12.0) 44.8 6.78 S 115.5 
3eq 2.81 dd (17.0, 3.0)    
4  194.0  193.3 
5 7.40 d (8.0) 118.3 7.22 d (8.0) 114.8 
6 6.90 d (8.0) 111.0 7.09 d (8.0) 113.0 
7  152.2  153.6 
8  136.5  135.6 
9  152.0  148.0 
10  113.8  119.4 
1'  131.5  125.6 
2' 7.04 d (2.0) 115.3 7.60 d (1.8) 119.2 
3'  145.0  147.7 
4'  146.5  149.0 
5' 6.82 d (8.5) 116.5 6.86 d (8.0) 116.7 
6' 6.92 dd (8.5, 2.0) 118.6 7.39 dd (8.0, 1.8) 126.7 
Glc 1 4.98 d (7.8) 102.6 5.00 d (7.8) 102.9 
2 3.54 dd (9.0, 7.8) 74.7 3.60 dd (9.5, 7.8) 74.5 
3 3.51 t (9.0) 77.6 3.50 t (9.5) 77.7 
4 3.42 t (9.0) 71.6 3.43 t (9.5) 71.8 
5 3.72 m 75.6 3.73 m 76.2 
6a 4.45 dd (12.0, 3.0) 65.0 4.49 dd (12.0, 3.0) 65.0 
6b 4.28 dd (12.0, 5.0)  4.30 dd (12.0, 4.5)  
COCH3  172.0  172.7 
COCH3 2.14 s  20.8 2.10 s  21.1 
Data assignments were confirmed by DQF-COSY, 1D-TOCSY, HSQC, and  
HMBC experiments 
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CONCLUSIONS 
 
This thesis work reported the results of the phytochemical study of Siparuna thecaphora 
(Poepp. Et Endl) A.DC, Bidens humilis (Kunth), Andromachia igniaria (Humb.& Bonpl.), 
Euphorbia laurifolia (Juss. Ex Lam.), and Clinopodium tomentosum (Kunth) Harley. These 
plants belong to Ecuadorian flora and have not been studied before for their chemical 
content, nevertheless they are used in traditional medicine in Ecuador, and also belong to 
genus that demonstrated to be interesting according to information reported in the literature. 
Chromatographic separation led to the isolation of 60 compounds, elucidated by extensive 
spectroscopic and spectrometric methods, of which 13 are new (Figures 8.1, 8.2, 8.3 and 
8.4) and 47 known and belong to different classes of secondary metabolites such as 
monoterpene, phenolics, diterpenes and flavonoids. 
The detailed results of the research for each plant are reported in Chapters 3-7.   
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Figure 8.1: New isolated compound from S. thecaphora, see Chapter 3  
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Figure 8.2: Structure of new compound isolated from C. tomentosum, see Chapter 4 
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Figure 8.3: New isolated compounds from E. laurifolia, see Chapter 5 
 
Since diterpenes from Euphorbia genus are reported to show important antitumor activity, 
the antiproliferative  activity of compound 10 was preliminary assayed against human 
prostate cancer (PC-3) and human breast adenocarcinoma (MCF7) cell lines, showing an 
IC50 value of 25 µM at 24 and 48 h. In order to identify compound 10 molecular target a 
Drug Affinity Responsive Target Stability (DARTS) method was performed, and Clathrin 
heavy chain 1was found to be a possible target. These are preliminary results that will be 
confirmed and validated in a future work. 
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Figure 8.4: Structures of new compounds isolated from B. humilis, see Chapter 6 
 
The 2,2-Diphenyl-2-picrylhydrazyl (DPPH), β-carotene bleaching (BCB) and ferric 
reducing antioxidant power (FRAP) assays were applied to all the extracts. Total Phenolic 
Content (TPC) was also measured in each case. The n-BuOH fraction demonstrated to be 
the one containing the highest concentration of total phenolics thus was subsequently 
submitted to chromatographic separation to obtain less complex fraction and finally isolate 
compounds that were also test by the same assays to screen their antioxidant activity. Most 
of the isolated compounds are flavonoids; considering their structure the leading role of two 
hydroxyl groups in the ortho-diphenolic could be responsible of the antioxidant activity. 
The presence of additional phenolic compounds (Chapter 6) detected thanks to LC-
HRESIMS and LC-HRESIMS/MS analyses carried out with the n-BuOH extract could 
explain the antioxidant activity of B. humilis n-BuOH extract. 
 
 
Conclusions Chapter 8 
 
- 73 - 
 
2
34
10
6
97 O
O
RO
OH
OH
1'
5'
4'
8
5
2'
OH
3'
6'
2
34
10
6
97 O
O
RO
OH
OH
1'
5'
4'
8
5
2'
OH
3'
6'
OHO
HO
CH2
OH
O C
O
CH3
R=
1 17
 
Figure 8.5: New compounds from A. igniaria, see Chapter 7 
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LIST OF ABBREVIATIONS 
AA: antioxidant activity 
AcOEt: ethyl acetate 
AcOH: acetic acid 
acylCoA: coenzyme A 
ATP: adenosine triphosphate 
BCB: β-Carotene bleaching 
BHT: butylhydroxytoluen 
1D-2D: mono e bidimensional 
CD: circular dichroism 
CD3OD: deuterate methanol 
CH3CN: acetonitrile 
CHCl3: Chloroform 
13
C-NMR: carbon nuclear magnetic resonance 
COSY: correlation spectroscopy 
CeSO4:  ceric sulfate 
C-terminal: carboxy-terminal 
DAD: diode array detector 
DARTS: Drug Affinity Responsive Target Stability  
DEPT: Distortionless Enhancement by Polarization Transfer 
DMSO: dimethyl sulfoxide 
DPPH: sodium acetate trihydrate 
DQF: double-quantum filtered 
DTT: dithiothreitol   
ESI-MS: electrospray mass spectrometry 
FRAP: Ferric reducing antioxidant power  
g: gram 
GLC: glucose 
HCl: chloridic acid 
HMBC: heteronuclear multiple bond correlation  
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1
H-NMR: proton nuclear magnetic resonance spectroscopy 
HPCPC: high performance centrifugal partition chromatography 
HPLC: high pressure liquid chromatography 
HR-MS: high-resolution mass spectrometry 
HRESIMS: high resolution electrosray mass spectrometry 
H2SO4: sulfuric acid 
HSQC: heteronuclear single quantum correlation 
Hz: hertz 
IAA: iodoacetamide 
IC50: inhibitory concentration half maxima 
J: NMR coupling costant 
kDa: kilodaltons 
KOH: potassium hydroxide 
LC-MS: liquid chromatography coupled with mass spectrometry 
MCF7: human breast adenocarcinoma cell line 
m/z: mass/ charge  
MeOH: methanol 
mg: milligram 
MHz: mega Hertz 
MS: mass spectrometry 
MSn: mass spectrometry tandem 
n-BuOH: normal-butanol 
n-hexane: normal hexane 
NMR: nuclear magnetic resonance 
NOESY: nuclear overhauser effect spectroscopy 
NTS: Naturstoff reactive 
PBS: phosphate buffered saline 
PC3: human prostate cancer cell line 
PEG: polyethylene glycol 4000 
ppm: parts per million 
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Q-TOF: quadrupole- time of flight 
RACI: Relative Antioxidant Capacity data Index 
ROESY: rotating frame Overhause effect spectroscopy 
RNA: ribonucleic acid 
RP: reverse phase 
SDA-PAGE: sodium dodecyl sulfate polyacrylamide gel electrophoresis 
TLC: thin layer chromatography 
TOCSY: total correlation spectroscopy 
TPC: total polyphenolic content 
TPPI: Time Proportional Phase Increment 
TPTZ: 2,4,6-tripyridyl-s-triazine 
tR: retention time 
UV: ultraviolet-visible 
µg: microgramm 
µM: micromolar 
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